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ABSTRACT OF THE DISSERTATION
Mechanism of Lmx1b-regulated Limb Dorsalization
by
Jennifer Feenstra
Doctor of Philosophy, Graduate Program in Anatomy
Loma Linda University, June 2012
Dr. Kerby Oberg, Chairperson
Lmx1b, a LIM homeodomain transcription factor is necessary for limb, kidney,
eye, and central nervous system development. Lmx1b knockout (KO) mice display;
abnormal limb dorsalization with distal ventral-ventral limbs, nephropathy, ocular
malformations, loss of dopaminergic/serotonergic neurons, and reduced cerebellum and
tectum formation. The developmental mechanisms utilized by Lmx1b remain largely
unknown; to investigate downstream targets, we have used the limb as a model because
of its accessibility and striking Lmx1b KO phenotype.
To identify candidate genes, we compared gene arrays from Lmx1b KO and
wildtype mouse limbs during limb dorsalization, i.e., 11.5, 12.5, and 13.5 days post
coitum. We identified 54 target genes differentially expressed in all three stages. An
abundance of extracellular matrix-related targets were found to be regulated by Lmx1b,
including collagens and proteoglycans. Three Lmx1b-regulated proteoglycans, are
clustered together at one genomic locus, Keratocan, Lumican, and Decorin (KLD). To
determine whether Lmx1b’s regulation of these targets is direct, we used in silico
comparative genomic analysis and identified a potential regulatory region with a known
Lmx1b binding site (Peak 3). We hypothesized that Lmx1b directly regulates KLD via
Peak 3. We isolated Peak 3 and linked it to a green fluorescent protein (GFP) reporter.

xviii

This construct was electroporated into chick embryos at the primitive streak stage
(Hamburger-Hamilton (HH) 4) and during early neural tube formation (HH10). GFP
expression was detected in neural tube and surrounding the developing midbrain and
cerebellum. Expression of Lmx1b and KLD mRNA overlaps the activity of this
regulatory region.
Our data suggests Lmx1b regulates morphogenesis by altering the extracellular
matrix composition such as KLD proteoglycans. Furthermore, the activity of KLDassociated Peak 3 localized to Lmx1b-dependant CNS structures during development
supports a direct role for Lmx1b regulation.

xix

CHAPTER ONE
INTRODUCTION

The Developing Limb
Around 1 in 600 human newborns present with some form of upper limb
abnormality (Flatt AE 1977). Characterization of the molecular pathways that orchestrate
limb development is essential to understanding the etiology, diagnosis and possible
interventions for patients with limb malformations. Additionally, the limb is a powerful
developmental model to examine how patterned structures arise. Therefore, the molecular
mechanisms which orchestrate limb development have been the focus of intense study for
several decades.
During early embryonic development, homeobox (Hox) transcription factors set
up a segmental body plan along the cranial-caudal axis (Burke, Nelson, Morgan, &
Tabin, 1995). Around the fourth week of human development, the presumptive limb
fields are established, triggering the expression of Tbx5, Wnt and Fgf proteins that
initiate limb outgrowth (Burke, et al., 1995). The limb bud emerges as a bulge of lateral
plate mesoderm covered by a thin outer layer of ectoderm (Fig. 1.1). Following formation
of the limb bud, development proceeds along three axes: proximal-distal, anteriorposterior (radial-ulnar), and dorsal-ventral (Fig. 1.1).
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Figure 1.1) Limb Bud Coordinate Axes and Signaling Centers
The forelimb (boxed region, A) of a Carnegie stage 13 (Moore, Hutchins, & O'Rahilly,
1981) embryo is depicted with the three coordinate axes (B, C), each with their own
signaling center. The apical ectodermal ridge (AER - orange) coordinates proximal-distal
(Pr-Di) outgrowth and differentiation. The zone of polarizing activity (ZPA - purple)
controls radial-ulnar asymmetry. The dorsal ectoderm (green) regulates dorsal-ventral
(Do-Ve) asymmetry. Within the FGF responsive zone (FRZ - blue), the fate of
mesodermal cells are determined by these signaling centers. The axes and signaling
centers are shown in different orientations; (B) Dorsal view, and (C) Lateral, end on view
(Modified from Oberg, Greer, & Naruse, 2004).

Formation of the Proximal-Distal and Anterior-Posterior Axes
Development and differentiation of each axis is controlled by a population of cells
that signal patterning information to local cells and organize tissue along its axis, i.e.,
signaling centers. Mesodermal Fgf10 at the apical dorsal-ventral boundary induces
ectodermal thickening to form the signaling center for the proximal-distal axis, the apical
ectodermal ridge (AER) (Zakany, Zacchetti, & Duboule, 2007). The AER, in turn,
secretes Wnt3 and several Fgf proteins (Fgf4, 8, 9 & 17), which maintain Fgf10
expression in the underlying mesoderm. Fgf10 sustains the proliferation of a sub-AER
population of cells termed the Fgf responsive zone (FRZ) (Boehm et al., 2010). This
2

reciprocal loop of ectodermal and mesodermal Fgf/Wnt proteins maintains proximaldistal outgrowth (Barrow et al., 2003; Kawakami et al., 2001).
Development and differentiation along the anterior-posterior (radial-ulnar) axis is
controlled by the zone of polarizing activity (ZPA) in the posterior (ulnar) limb
mesoderm. The ZPA expands limb width and posteriorizes (ulnarizes) the developing
limb through a secreted morphogen, sonic hedgehog (SHH) (Riddle, Johnson, Laufer, &
Tabin, 1993). The AER and the ZPA are closely linked by a reciprocal feedback loop
that maintains SHH expression adjacent to the distal posterior (ulnar) border of the AER
during progressive outgrowth (Lee Niswander, Jeffrey, & Martin, 1994; Sun et al., 2000).

Figure 1.2) Molecules Linked to Dorsal-Ventral Limb Development
Graphic representation of the molecular interactions initiating dorsal-ventral axis
formation. Wnt7a expression in the dorsal ectoderm is denoted by blue, the boundary
between dorsal and ventral is demarcated by the green dot (Radical Fringe) and En-1 in
the ventral ectoderm is orange. Lmx1b expression along the dorsal compartment is shown
in red, arrow in dorsal compartment indicates Lmx1b induction via Wnt7a. (+ indicates
the molecule is a dorsalizing factor)

3

Formation of the Dorsal-Ventral Limb Axis
Patterning of the dorsal-ventral axis begins with delineation of the dorsal and
ventral limb compartments (Fig 1.2). Initially the secreted protein Wnt7A is expressed in
the presumptive limb ectoderm. The transcription factor Engrailed 1 (En-1) is induced by
Bone Morphogenic Proteins in the ventral ectoderm. En-1 restricts Wnt7A expression to
the dorsal ectoderm, where Wnt7A dorsalizes the underlying limb mesoderm through the
induction of the Lim homeodomain transcription factor Lmx1b (Riddle et al., 1995;
Vogel, Rodriguez, & Warnken, 1995). The role of each of these molecules in dorsalventral patterning is described in further detail below.

Wnt7A
The Wnt family of secreted proteins is essential for normal limb formation and
several Wnt proteins are differentially expressed during limb outgrowth. Secreted Wnt7a
in the dorsal ectoderm upregulates the expression of Lmx1b in the dorsal mesoderm and
also modulates posterior Shh expression in the ZPA, thereby influencing both anteriorposterior and dorsal-ventral axis formation. Functional absence of Wnt7a in knockout
mice causes ventralization of dorsal limb structures, i.e., a ventral-ventral limb with
footpads on the dorsal autopod surface (Chen et al., 1998; Cygan, Johnson, & McMahon,
1997). In contrast, misexpression of Wnt7a in the ventral ectoderm induces Lmx1b
expression in the ventral limb compartment and a subsequent dorsal-dorsal limb
phenotype (Loomis, Kimmel, Tong, Michaud, & Joyner, 1998). In humans, mutations of
WNT7A are associated with Fuhrman syndrome or Al-Awadi/Raas-Rothschild/Schnizel
phocomelia. Fuhrman syndrome may arise from one or more mutations found in the
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third exon of WNT7A correlated to bowing of the femoral bone, absent fibula and/or
ulna, polydactyly, syndactyly, oligodactyly, hyploplastic fingers and fingernails (Woods
et al., 2006). Al-Awadi/Raas-Rothschild/Schnizel phocomelia is associated with a
mutation in the fourth exon of WNT7A associated with a variation of symptoms
including absence of the ulna, pelvis, uterus and/or fibula or the more pronounced
anomaly phocomelia (Lonardo, Sabba, Luquetti, Monica, & Scarano, 2007).
The striking morphological changes in both the Wnt7a KO mouse model and in
the human studies have established a role for ectodermally expressed Wnt7a as an
organizer of the dorsal-ventral limb axis with contributions to the anterior-posterior axis.
Wnt7a is essential for up-regulation of Lmx1b in the underlying dorsal mesoderm, which
initiates the cascade necessary for limb asymmetry along the dorsal-ventral axis.
Although Lmx1b conveys dorsal limb fates, the mechanism by which Wnt7a induces
Lmx1b remains to be shown.

Engrailed-1
Engrailed-1 (En-1) is a homeobox transcription factor expressed in the ventral
ectoderm, which restricts Wnt7a to the dorsal mesoderm. In the mouse, loss of En-1
allows Wnt7a to maintain its expression in the ventral ectoderm, thereby creating a
dorsal-dorsal limb phenotype (Loomis, et al., 1998). In contrast loss of Wnt7a does not
alter or expand En-1 expression and produces a ventral-ventral limb (Parr & McMahon,
1995). Since cells not under the influence of En-1 produce a ventral morphology, it has
been suggested that the presumptive limb field is programmed with a ventral
specification i.e. the default pathway of the limb is ventral (Chen & Johnson, 1999).

5

Therefore, the presumptive limb is specified as ventral until intervention by Wnt7a which
induces Lmx1b, thereby effectively dorsalizing the limb.

Lmx1b
Lmx1b is a LIM-homeobox transcription factor comprised of eight exons that
produce a 7kb mRNA (Dunston, Hamlington, et al., 2004). Exon 7 can be alternatively
spliced to produce two predicted proteins of 372 and 379 amino acids. It is currently
unknown if these isoforms have any functional difference. The second and third exon of
Lmx1b contains two N-terminal LIM-domain regions, characterized by two tandem
repeats of cysteine/histidine and zinc finger domains. LIM-domains represent potent
protein-protein interaction motifs and have been studied in many fields including
cytoskeletal organization, organ development and oncogenesis. Found in exon four, five
and six is a DNA/RNA binding homeodomain region, which is highly conserved (99%)
between mouse and human. Using electrophoretic mobility-shift assays it has been shown
that the Lmx1b homeodomain binds to the FLAT sequences, i.e. FLAT-E (TAATTA)
and FLAT-F (TAATAAT) (Rohr et al., 2002). Many well-known homeobox transcription
factors have been characterized as selector genes, which are considered to be or act as
master switches with the ability to transcriptionally enhance or repress other genes
(Kuziora & McGinnis, 1988).
Due to its functionally interactive structure and classification as a selector gene, it
is not surprising that Lmx1b is essential for the correct development of several organ
systems. In humans, loss of one Lmx1b allele (haploinsufficiency) causes Nail Patella
Syndrome (NPS) (Chen, et al., 1998). Although commonly known as NPS this syndrome
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may also be referred to as Onychoosteodysplasia, Turner-Kieser Syndrome, or Fong
Disease. Mutations of the Lmx1b gene cause NPS and occur mainly within the LIM
domains (82%) and the homeodomain (18%) (E. M. Bongers, Gubler, & Knoers, 2002),
enhancing the importance of these regions for Lmx1b function. NPS is an autosomal
dominant disorder symptoms of which can include nephropathy, open angle glaucoma,
inhibition of dopaminergic/serotonergic neurons and various skeletal abnormalities
including absent patella, elbow dysplasia, iliac horns and reduced/malformed nails.
The Lmx1b gene is highly conserved between mouse and human. To delineate the
role and mechanism of Lmx1b during development, a functional mouse knockout
(C57BL/6 background) was generated by replacing the first LIM domain and the
homeodomain with a neomycin cassette (Chen et al., 1998). Interestingly, the
heterozygous mutants (Lmx1b +/-), analogous to the human condition, do not exhibit a
phenotype. However, the complete lack of Lmx1b function in these mice (Lmx1b -/-)
produces NPS-associated organs with a much more severe pathology than seen clinically.
The examination of NPS patients and generation of the Lmx1b KO mouse model has
helped to delineate the functional roles for Lmx1b during development. These roles are
reviewed below.

Functional Roles of Lmx1b during Development
Kidney Development
Renal dysfunction is considered the most life threatening of all the NPS
symptoms, the homozygous Lmx1b KO mice display severe kidney defects including
large glomerular leaks along the vasculature causing proteinuria and death (Chen, et al.,
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1998). The glomerulus and surrounding Bowmans capsule make up the basic filtration
system of the kidney. The glomerulus has a unique basement membrane that forms the
boundary between the blood and urinary spaces and is flanked by a layer of podocytes.
The processes extending from podocytes determine the size-selectivity of the filtration
barrier. Podocytes are responsible for secreting basement membrane components
including collagens and proteoglycans. Lmx1b directs podocyte differentiation and
maintenance, thereby enabling formation of the distinct collagen fibril composition of the
glomerular membrane (Rohr, et al., 2002). Specifically, in the mouse at 13.5 days post
coitum (dpc), Lmx1b is expressed in presumptive glomerulus and persists in the visceral
glomerular epithelium into postnatal life. Loss of Lmx1b causes disorganization of the
glomerular basement membrane and disruption and/or fusion of podocyte processes
(Morello et al., 2001). The disruption of these layers causes the renal dysfunction seen in
NPS patients and the Lmx1b KO mouse. In Lmx1b KO mice, there is a decrease in the
expression of collagen IV types (isoforms) three and four in the glomerular basement
membrane. Additionally, studies using a podocyte-specific Lmx1b KO mouse
demonstrate the importance of Lmx1b in initial development and maintenance of
podocytes in the perinatal mouse (Suleiman et al., 2007). Interestingly, patients with
Alport Syndrome, which is caused by a collagen gene mutation, develop similar
nephropathy to NPS patients, further supporting the concept of collagen regulation during
glomerular basement membrane formation (E. M. Bongers, et al., 2002).
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Eye Development
Abnormal ocular structures are not common with NPS patients; however,
congenital cataract, microcornea and sclerocornea have been noted in the literature. Also
approximately 50% of NPS patients will develop clinical symptoms of open angle
glaucoma (Lichter et al., 1997; McIntosh et al., 1998; Mimiwati et al., 2006). In the
mouse, Lmx1b expression begins around 10.5 dpc in the periocular mesenchyme
followed by a localization to the anterior eye including corneal endothelium, iris ciliary
body and trabecular meshwork (E. M. H. F. Bongers et al., 2005; Pressman, Chen, &
Johnson, 2000). Loss of Lmx1b causes cornea stromal defects and hypoplasia of the iris
and ciliary body possibly causing an increase in intraocular pressure responsible for the
open angle glaucoma commonly seen in NPS patients and the Lmx1b KO mouse.
Together the morphology of NPS patients and the Lmx1b KO mouse demonstrate the
importance of Lmx1b for establishing of the anterior segments of the eye.

Central Nervous System Development
A role for Lmx1b during CNS development has also been suggested. During
CNS development, the isthmus organizer is a signaling center responsible for midbrain
and hindbrain formation. In the mouse, Lmx1b is expressed in the isthmus organizer
beginning at 9 dpc (Guo et al., 2007). In the Lmx1b KO mouse, genes normally
associated with development of the isthmus are not expressed (Fgf8, Wnt1, En1, En2 and
Pax2). Subsequently loss of Lmx1b causes a severe reduction of not only the midbrain
dopaminergic neurons but also the tectum and cerebellum (Guo, et al., 2007). The tectum
is part of the midbrain that contains the superior and inferior colliculi responsible for
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visual and auditory receptors respectively. The cerebellum in Lmx1b KO mice is smaller
but appears normally patterned indicating that Lmx1b is responsible for growth but not
patterning of the cerebellum.
Lmx1b is also responsible for determining serotonergic neurons of the hindbrain
(Y. Ding et al., 2003). Loss of serotonergic signaling is thought to contribute to several
mental disorders including anxiety, depression, addictions, and post-traumatic stress.
Correspondingly, NPS patients seem to be predisposed to attention deficit hyperactivity
disorder and major depressive disorder, although they have normal intelligence with no
apparent learning disorders (Lopez‚Arvizu et al., 2011).
Lastly, Lmx1b is expressed in the dorsal interneurons of the spinal cord where it
contributes to assembly of pain circuitry and differentiation/ migration of sensory
neurons/afferent fibers (Y. Q. Ding et al., 2004). In the Lmx1b KO mouse, no synaptic
contacts are formed between the dorsal horn neurons and nociceptive afferent neurons
responsible for pain response (Y. Q. Ding, et al., 2004). Similarly, NPS patients
experience neurological deficits such as diminished pinprick sensation and tingling or
numbness in the limbs (Dunston, Reimschisel, et al., 2004).

Limb Development
Lmx1b is robustly expressed in the dorsal mesodermal compartment of the
developing limb. In the mouse, strong Lmx1b expression can be detected in the dorsal
compartment at 10.5 dpc. With stage progression, Lmx1b expression fades in the
proximal tissue but remains strong in the distal limb/ autopod until 15.5 dpc (Riddle, et
al., 1995; Vogel, et al., 1995). NPS patients demonstrate a disruption of dorsal limb
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Figure 1.3) Autopod Architecture in WT and Lmx1b KO Mice
Scanning electron micrographs of the external architecture of - A) wild type (WT) and B)
Lmx1b knockout (KO) autopods. A’) The tendon architecture in a digit from a WT
mouse with normal dorsal-ventral asymmetry. B’) In a digit from an Lmx1b KO mouse
the dorsal tendons are ventralized. – lumbricals (LM), dorsal interosseous (IO), dorsal
hood (DH), proximal interphalangeal (PIP) joint, metacarpal phalangeal (MP) joint,
extensor digitorum communis (EDC), flexor digitorum sublimes (FDS), flexor digitorum
profudus (FDP); LM’, FDS’, and FDP’ indicate ventralized “dorsal” tendons.
(A/B Adapted from Chen et. al. 1998, A’/B’ Dr. Takuji Naruse unpublished data)

structures such as the patella and nails (Vollrath et al., 1998) while the Lmx1b KO mouse
limb displays a complete loss of distal symmetry with ventral-ventral morphology of the
joints, tendons, limb musculature and nerves (Chen, et al., 1998) (Fig 1.3).
Lmx1b is essential for normal dorsal-ventral limb axis formation. Loss of Lmx1b
causes distal ventral-ventral limb symmetry while overexpression of Lmx1b forms
dorsal-dorsal structures (Chen & Johnson, 2002; Cygan, et al., 1997; Loomis, et al.,
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1998) indicating Lmx1b is both necessary and sufficient for distal limb dorsalization.
Additionally, recent fate mapping experiments in the chick and mouse (Arques, Doohan,
Sharpe, & Torres, 2007; Pearse, Scherz, Campbell, & Tabin, 2007; Qiu, Chen, &
Johnson, 2009) have shown Lmx1b-expressing cells create or define the dorsal limb
compartment. Moreover, while Lmx1b does not initiate compartment formation it is
essential for dorsal compartment maintenance and dorsal morphogenesis.
Collectively, these data indicate that Lmx1b is responsible for limb dorsalization,
however, the mechanism and downstream targets remain to be determined. Thus, the
underlying objective of this study is to discover the mechanism of Lmx1b-regulated
limb dorsalization.

Dissertation Hypothesis
Based on the evidence from literature, I hypothesized that Lmx1b dorsalizes the
limb by modifying the expression of genes involved in the formation of joints,
ligaments, tendons and bones. I investigated this hypothesis through the following
specific aims.

Project Specific Aims
Specific Aim 1.) Identify Genes in the Dorsal Mesoderm Regulated by
Lmx1b During Limb Development
Rationale and Approach
Haploinsufficiency of Lmx1b in Nail Patella Syndrome (NPS) patients and
complete loss of Lmx1b in the KO mouse indicate the significance of Lmx1b to pattern
the dorsal tissues of the limb. However, downstream Lmx1b targets in the limb are
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currently not well characterized. Thus, my working hypothesis was that Lmx1b altered
downstream skeletal and soft tissue targets, causing asymmetrical limb patterning.
To examine this hypothesis and discover potential Lmx1b gene targets, we used
microarray analysis and compared Lmx1b KO mice to wildtype littermates. Specifically
we targeted stages during limb dorsalization and limb tissues with robust Lmx1b
expression (11.5-13.5 dpc). Genes differentially expressed in the microarray analysis
were validates with Real-time PCR. Additionally, whole mount in situ hybridization
(WMISH) was performed to determine the corresponding tissue pattern of expression for
the validated Lmx1b target genes.

Outcomes
Targets discovered that were differentially expressed in the microarray, validated
by Real-time PCR and asymmetrically expressed along the dorsal-ventral axis included a
variety of genes ranging from angiogenesis to skeletal formation. Interestingly, a
significant portion of genes discovered were extracellular matrix molecules such as
Collagen11a2, Collagen9a3, Aggrecan, Lumican, Decorin, Keratocan. We also
discovered several genes that are known to associate with or accentuate proteoglycan
function including Matrilin1, Matrilin4 and Lysyl oxidase. From these findings I
concluded that Lmx1b may function to regulate extracellular matrix composition, thereby
patterning developing tissues. See chapter three for the detailed description and
discussion of these experiments published in Development, Growth, and Differentiation.
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Specific Aim 2.) Determine Direct Induction of Downstream Lmx1b
Targets
Rationale and Approach
I consider genes discovered in Specific Aim 1 to be downstream Lmx1b targets, a
preponderance of which are extracellular matrix molecules. The discovery of multiple
extracellular matrix molecules suggests that Lmx1b dorsalizes the limb, at least in part,
by changing extracellular matrix composition. Among these extracellular matrix
molecules were four proteoglycans, three of which (Keratocan, Lumican, Decorin) were
dorsally expressed in the mouse limb at 12.5 dpc. Thus, my working hypothesis was that
Lmx1b directly regulates the proteoglycans: Keratocan, Lumican and Decorin.
To confirm this direct relationship, we chose to use the chick as a bioassay
because of its accessibility and our ability to focally manipulate gene expression. We
successfully developed an avian retroviral construct, which expresses human Lmx1b. In
addition, we used an electroporation technique to focally express the construct in the
ventral wing mesoderm of the chick and induce dorsalization of ventral tissues. (see
Chapter 2).
However, when I performed WMISH using Keratocan, Decorin and Lumican in
the chick, I discovered that these targets, which are dorsally-restricted in the mouse, are
expressed in the dorsal and ventral wing mesoderm. Thus, native expression of
Keratocan, Lumican, and Decorin in the chick wing was different from the mouse and
would impair our ability to determine up-regulation via our humanLmx1b construct.
Thus, we abandoned the chick as a bioassay to demonstrate direct Lmx1b regulation of
these proteoglycans as originally planned. Instead we reported these unique differences
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in expression and refocused our energies on other techniques to determine direct Lmx1b
regulation as outlined in Specific Aim 3.

Outcomes
Many developmental pathways are conserved across vertebrate species. Thus,
this disparate expression between chick and mouse was not expected. To clarify this
discrepancy, we performed a detailed temporal and spatial expression pattern analysis of
these proteoglycans (Decorin, Lumican and Keratocan) during dorsalization, comparing
both forelimbs and hindlimb in the chicken and mouse models. Our analysis
demonstrated a marked species-specific difference in the expression patterns of these
proteoglycans. We also included Aggrecan which is expressed in proliferating
chondrocytes and is conserved between chick and mouse. Our publication describing this
disparate proteoglycan expression pattern is detailed in chapter four.

Specific Aim 3.) Determine the Mechanism by which Lmx1b
Regulates Direct Downstream Targets
Rationale and Approach
New sequencing technologies have allowed the field of genetics to flourish.
Furthermore, new sequences from evolutionarily diverse species are being added to
public databases regularly. This has created new opportunities to compare evolutionary
gene changes across species which may correspond to function. In particular, we are
interested in the discovery of noncoding sequences that participate in gene regulation
called cis-regulatory regions. These regulatory regions can lie nearby or significantly
up/downstream of their target genes (Gomez-Skarmeta et al., 2006; Pfeifer et al., 1999)
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Regulatory functions that are conserved across species typically maintain these noncoding sequences and appear to evolve more slowly than associated coding sequences
(Blanchette and Tompa, 2003). To identify these conserved noncoding regions (CNRs),
we used VISTA Genome Browser (http://pipeline.lbl.gov/cgi-bin/GenomeVista, Kent et
al.,2002;Frazer et al., 2004 ). VISTA compares the human genome to many diverse
species and indicates areas of conservation in increments of 100bp intervals. For our
analysis we used dog, mouse, opossum, and chicken. We initially examined Keratocan
since it revealed the greatest fold-change in the microarray analysis and WMISH of
Keratocan was undetectable in the Lmx1b KO mouse limb. When we examined the
location of Keratocan on the genome, we recognized that Lumican and Decorin lie just
upstream (5’) of Keratocan. We referred to this cluster of three proteoglycan genes as the
KLD locus. Additionally, 5’ to the KLD locus is a 900kb gene desert, a region devoid of
protein coding genes. When searching for conserved sequences, gene deserts have been
shown to be regions rich in regulatory elements. VISTA analysis produced 12 CNRs
surrounding the KLD locus. Using more detailed genomic alignment, we discovered two
of the CNRs, Peak3 and Peak10, contain FLAT sequences (potential Lmx1b binding
sites) which are conserved across the multiple species we examined. Thus, my working
hypothesis for this specific aim was that Lmx1b binds to its specific binding site
(FLAT sequence) within Peak3 and Peak10 to directly regulate Keratocan, Lumican
and/or Decorin.
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Outcomes
Peak3 and Peak10 constructs were electroporated into the primitive streak stage
chick embryo and allowed to incubate to HH14 to determine activity. Peak10 showed no
activity in the early embryo but Peak3 showed activity in the neural tube and developing
brain vesicles beginning around HH10. Later CNS targeted expression of Peak3 reveals
activity surrounding the developing brain vesicles at HH19/20. Isolation and
overexpression of the FLAT binding site in the developing brain also shows activity
indicating the FLAT site may be the region necessary for Peak3 activity. Together we
believe this indicates that Lmx1b uses the FLAT site of Peak3 to direct KLD expression
in the developing brain. Data acquired to support this aim is presented in chapter 5.
Peak3 and Peak10 were also electroporated into the presumptive limb at HH14
and monitored for GFP every 24 hours from HH19-HH25. However no activity was
detected for Peak3 or Peak10 in the chick limb.

Specific Aim 3.) Alternate Strategy
Rationale and Approach
In addition to the identification of regulatory regions using software methods,
newly developed next generation sequencing techniques have not only emerged but have
now become affordable. The combination of next generation sequencing and chromatin
immunoprecipitation (ChIP-seq) is a powerful tool to examine DNA-protein interactions.
Our goal is to use ChIP to isolate Lmx1b-bound chromatin during limb development,
when Lmx1b is expected to interact with DNA to actively regulate transcription
responsible for dorsalization (12.5dpc). At 12.5 dpc limbs are harvested and fixed using
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formaldehyde to reversibly cross-link DNA-protein complexes. The chromatin is then
fragmented and combined with a high affinity Lmx1b antibody. The chromatin bound to
Lmx1b is isolated and purified for sequencing. For our experiments, a high affinity
Lmx1b antibody is available (Suleiman, et al., 2007). However to implement ChIP-seq a
significant challenge remains, a direct downstream target that will act as a positive
control is important for optimization. Currently the only reported direct downstream
targets of Lmx1b are in the kidney.
In the kidney, podocytes secrete basement membrane components including
collagens and proteoglycans. Lmx1b directs podocyte differentiation and maintenance,
and loss of Lmx1b causes aberrant basement membrane formation, thereby preventing
normal glomerular filtration (Rohr, et al., 2002). Two genes have been implicated as
direct downstream Lmx1b targets in the kidney: Col4a4 and Nphs2 (Rascle et al., 2009).
The disruption of renal morphology in the Lmx1b KO mouse, suggests that kidney
development is similar to limb development, with Lmx1b regulating extracellular matrix
during morphogenesis. Therefore, we believe targets discovered in embryonic kidney
cells using ChIP-seq may overlap with, and also expand, our understanding of Lmx1bmediated limb patterning. We hypothesize that Lmx1b regulates Keratocan, Lumican
and Decorin (KLD) by binding to predicted CNRs of the KLD locus during
development.

Outcome from Alternate Strategy
Human Embryonic Kidney (HEK) cells have been grown in culture and
transfected with an Lmx1b-hemagglutinin (HA) tagged construct. Lmx1b-HA cells were
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harvested to extract DNA, RNA and nuclear protein. We successfully amplified Lmx1b,
Col4a4 and Nphs2 from HEK RNA and the FLAT site of Col4a4 and Nphs2 from HEK
DNA by PCR. We also successfully detected enhanced Lmx1b protein levels in Lmx1bHA transfected HEK cells by Western blot. Since we determined the HEK cells
mimicked in vivo conditions, we continued with the ChIP-it Express Enzymatic kit from
Active Motif. Using the HA antibody, we were able to isolate Lmx1b-HA-bound
chromatin and subsequently confirmed the presence of the FLAT sequence by PCR.
However, we have had trouble immunoprecipitating enough chromatin for sequencing
purposes. Lmx1b may be a low abundance molecule so we will need to perform multiple
ChIP runs with a high number of cells. The progress of this alternative approach is
detailed in chapter 6.
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CHAPTER TWO
MATERIALS AND METHODS

Specific Aim 1 Methods
Lmx1b Mouse Model
The Lmx1b KO mouse was generated by Randy Johnson (Chen, et al., 1998). The
homeodomain and first LIM domain of the Lmx1b gene was conditionally knocked out
by inserting a neomycin cassette using the C57BL/6J mouse background. Males and
females are housed in separate cages with individual ventilation. Colony is maintained by
mating Lmx1b (+/-) males with Lmx1b (+/+) females, additionally new C57BL/6J
unrelated virgin females are ordered from Charles river every four months to maintain
genetic diversity of the colony. Time dated matings use heterozygous (Lmx1b +/-) males
mated with heterozygous females to obtain homozygous Lmx1b mutant or KO embryos
(Lmx1b -/-) and wildtype littermates (Lmx1b+/+). For colony maintenance matings male
(+/-) and female (+/+) mice were housed together for 14 days then separated to allow
female to deliver pups. For time dated matings female mice were placed in the male cage
for a 12 hour period, from 7pm to 7am with females checked in the morning for vaginal
plugs to confirm copulation. Noon on the day the vaginal plug was identified was
considered as 0.5 days post coitum (dpc). Pregnancy was determined by weighing
females on day 7 to determine a baseline weight then repeated on days 10/11/12/13
depending on stage required. Pregnant females on average will gain 1 gram per day, older
females with bladder problems can show sporadic weight gain, which does not increase
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over time. Colony Pups were weaned at four weeks after which tail snips were taken to
perform genotyping. Mice are anesthetized with Isoflurane in a closed chamber (200 μl/
750 ml) for 30 seconds. Approximately 1cm of the tail tip is removed and diced with a
sterile razor blade. Mouse tails are dipped in hemostatic powder to decrease bleeding then
placed back in cages and observed to ensure proper recovery from anesthesia. Diced tail
specimens are placed into 750 μl tube containing 250 μl of QuickExtract DNA extraction
solution (EPICENTER). Tails are vortexed for 15 seconds and incubated 6 minutes at
650C, vortexed again and incubated for 2 minutes at 980C. 5 μl of this solution was used
for PCR genotype analysis, primers used demonstrate the presence or absence of the
Neomycin (Neo) cassette inserted into the Lmx1b gene. Mice containing the Neo cassette
on both alleles are labeled mutants (-/-), one Neo copy are heterozygous (+/-), and normal
mice with no Neo insert are wild type (+/+). PCR parameters are as follows:
950C/5min (1cycle), 950C/15sec, 600C/30sec,720C /45sec (30cycles), 720C/7min
(1cycle), 40C ∞. Following timed matings pregnant females are anesthetized the day of
harvesting in the closed container with isoflourane. Females are sacrificed using cervical
dislocation after which embryos are rapidly removed under sterile conditions. Embryos
are removed from their gestational sac and placed in 1% phosphate buffered saline (PBS)
to continue cleaning. Heads were placed in QuickExtract DNA extraction solution
(EPICENTER) and used for genotyping in the same manner as tail snips. The digestive
tract, heart and urogenital tract are removed from embryos followed by overnight
incubation in MEMFA (0.1 mol ⁄L 3-(N Morpholino) propanesulfonic acid (MOPS), 2
mmol ⁄ L ethylene glycol tetraacetic acid (EGTA), 1 mmol ⁄ L MgSO4, 3.7%
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formaldehyde) at 40C. Following fixation embryos are rinsed in PBS and stored in 90%
Methanol at -200C.

Microarray Analysis
Lmx1b is a transcription factor utilized during the development of multiple organ
systems. In 1998, Col4a4 was discovered as a direct downstream target of Lmx1b in the
kidney. With this discovery it was thought that further determination of the Lmx1b
cascade would be imminent. However since that discovery nearly 14 years ago only one
additional direct downstream kidney target has been discovered (Nphs2). In order to
elucidate previously undiscovered downstream Lmx1b targets in the limb we utilized a
Lmx1b KO mouse model in conjunction with microarray analysis. Limbs were analyzed
during stages of initial tissue differentiation and Lmx1b expression using the Affymetrix
GeneChip® Mouse Genome 430 2.0 array. This array is a comprehensive analysis of the
mouse genome utilizing a powerful probe set of eleven mismatched oligoneucleotide
probes per transcription sequence for over 39,000 transcripts and variant sequences. Mice
were time-mated and embryos were harvested at 11.5, 12.5 and 13.5 days post coitum
(dpc). Embryos were placed in 1% PBS, heads were used for genotyping and limbs were
removed and stored in RNAlater (Ambion) at -800C. We harvested RNA from Lmx1b
+/+ and -/- littermate limbs using the RNeasy kit from Qiagen. We modified the protocol
slightly using three freeze thaw reactions with liquid nitrogen to crush the tissue. Buffer
RLT including 1ul/100ul B-Mercaptoethanol was added to tissue followed by a 10 min
incubation at room temperature before spinning in QIAshredder column. Final elution
was performed twice, 15ul each elution. RNA utilized was obtained from at least three
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separate litters producing three unique forelimb sets pooled together to minimize
biological variability. RNA was quantified with nanodrop spectrophotometer and around
12 μg was sent to University of California Irvine (UCI Genomics) where RNA and
microarray analysis was completed.

Figure 2.1) RNA Analysis done by UCI on 11.5 dpc Samples
An example of the RNA analysis done by UCI shows RNA sent in by our lab in Lanes
labeled 1-4 and RNA sent in from other labs in lanes 5-7. Lanes 1-2 are wildtype RNA
Lanes 3-4 are Lmx1b Knockout RNA.

Microarray data were received and uploaded to Comprehensive R based
Microarray Analysis web frontend (CARMAweb,
https://carmaweb.genome.tugraz.at/carma/). CARMAweb simplifies the statistical
programs R and Bioconductor to normalize and quantify fold-change and significance.
Data for each gene chip was normalized using JustRMA. Fold-change and significance
were determined using the Limma package which preforms a moderated t-test, since we
23

used two chips per group this was the most powerful statistical analysis, since it corrects
for possible sampling error. Note that chips for each stage were treated as replicates, for
example 11.5 dpc WT1 and WT2 data was normalized individually then treated as a
replicate data set to determine fold change and significance. Output analysis from
CARMAweb is annotated with Affymetrix probe data and can be easily exported to
Excel, any genes which display a significance of less than 0.005 were removed from
further analysis. The Excel document was searched to discover genes represented in more
than one array. Many genes were discovered in multiple arrays including genes upregulated at one stage and down-regulated in the next. However, for the purpose of this
study, we focused on genes up-regulated or down-regulated in all three stages since these
should represent Lmx1b specific targets rather than stage specific targets. The list of
genes discovered at all three stages was cross-referenced with literature and genes that
were sex specific were discarded.

Real-time PCR
Possible downstream target genes were analyzed by Real-time PCR to validate
microarray gene expression. Primers were generated for each gene target using
Sequencher 4.6, each primer set met several parameters including: an annealing temp
near 600C, 16-22bp length, GC clamp on 5’ and 3’ end, produces a amplicon of 50150bp. Primers were tested using mouse limb +/- cDNA libraries, resulting PCR was
purified and sent out for sequence analysis to determine primer specificity. Primers which
produced more than one amplicon were discarded. Real-time PCR was performed using
the Roche Lightcycler 2.0 and Roche recommended sybergreen mastermix reagents.
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Runs were standard for all target genes beginning with denaturation (950C for 5 minutes),
amplification 40 cycles (950 for 10seconds, 600 for 10 seconds, 720 for 10 seconds-data
acquisition), melting curve (950C for 10 seconds ramping at 0.1 degrees/sec continuous
acquisition). Melting curves were performed following RT runs to determine product
specificity. Lightcycler software was used to determine WT and KO fold change using
phosphoglycerate kinase (PGK) control samples to normalize gene expression (Crossing
point data) for each run. Each run was performed a minimum of 3 times, standard
deviation for each was calculated with Excel to create bar graph error bars found in figure
3.3.

Whole Mount in situ Hybridization
Primers were generated using the same parameters to pull down 700-1000bp
probe sequences in the chick and mouse models. Sequences were isolated and cloned
using the pCRTM II-TOPO (Invitrogen) vector. Constructs were screened for insert and
grown up overnight to perform Qiagen Miniprep, constructs with insert were sent for
sequencing to determine sequence fidelity. Sequences with few or no mutations are
isolated with PCR, then T7 is linked to PCR fragment using the Block-it kit by
Invitrogen. The linkage of T7 allows for a second PCR of both sense and antisense
strands using T7 and either the 5’ or 3’ gene specific primers. PCR products are purified
(Quiagen) and concentration is determined with the nanodrop spectrophotometer. Sense
and Antisense strands (1 μg) are transcribed using T7 enzyme in conjunction with a
Digoxigen labeled UTP to create the final Dig-labeled riboprobe (Block-it kit,
Invitrogen). Probes are treated with DnaseI and purified using Pellet Paint (Novagen).
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Probes were then heated to 75°C for 10 minutes placed on ice and diluted in cold
hybridization buffer to 10 ug/ml.
To determine 3-dimensional gene expression we utilized whole mount in situ
hybridization (WMISH) with digoxigenin-labeled riboprobes as previously described
(Yamada et al.,1999). Sterile reagents were made aloquated and frozen to ensure
cleanliness. Protienase K reactions were 30 min for 11.5dpc mice and HH 23 chick and
45min for 12.5-14.5 dpc mice and HH 23-29 chick. Hybridization of the transcribed RNA
probes was carried out at 60°C with stringent post-hybridization washes at 65°C. Sense
probes were also generated and tested to verify antisense probe specificity. Embryos were
checked every 20 minutes during colorization to ensure optimal probe staining then
washed with PBS, fixed in MEMFA and stored in 90% Methanol. We expect that genes
with confirmed differential expression overlapping Lmx1b expression during limb
development will be considered downstream targets. A minimum of two expression
pattern WMISH runs was done in both the chick and mouse using both upper or lower
limbs to establish a baseline expression pattern.

Specific Aim 2 and 3 Methods
Chick Model
Further studies of downstream Lmx1b targets were performed using the chick model
system. The chick is a longstanding invaluable model for limb development research
allowing researchers to perform in ovo experiments such as transplantations and AER
removal. These types of historic experiments have producing data, which substantially
increased our understanding of how the limb develops. The reasons for the chick model
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systems popularity include the ability to harvest sufficient numbers of chick embryos at
precise stages but most importantly the chick is readily accessible in the egg throughout
development.
For all experiments using chick embryos fertilized white leghorn chick eggs
(Chino Ranchers, CA) were incubated at 39°C in a standard humidified avian incubator.
Depending on the type of electroporation or harvesting the eggs were windowed and
staged according to Hamburger and Hamilton (HH,Hamburger & Hamilton, 1951).
WMISH of Lmx1b targets was also performed using comparable staged chick
embryos. Similar to mouse the chick embryos were harvested in phosphate buffered
saline, fixed in MEMFA overnight at 40C and stored in 90% Methanol at -200C.

Electroporation Studies
The accessibility of the chick limb means it can be surgically manipulated,
electroporated and/or treated with chemicals/proteins. In particular we use several
different types of electroporation in conjunction with two different vector delivery
systems. The first vector used is the pTK-EGFP which contains the the f1 phage origin;
an upstream SV40; a multiple cloning site (MCS); the Herpes simplex virus thymidine
kinase minimal promoter; an enhanced GFP reporter gene; and the ampicillin resistance
gene (Uchikawa et al., 2004). Plasmids were isolated from E. coli using the Qiagen
EndoFree Plasmid Maxi Kit to minimize lipopolysaccharide-related cytotoxicity and
improve transfection efficiency in chick embryos. The blank pTK-EGFP construct was
used as a negative control. The second vector system is an avian specific retroviral
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system RCASBP(A). This vector is replication competent, ampicillin resistant and
contains a ClaI insertion site (Hughes et al., 1987).
Whole embryo EP done at Hamburger-Hamilton (HH) stage 4, transfects the
entire embryonic disc just as it is begins gastrulation. Embryos can be followed in culture
for 48hrs up to HH14. Therefore electroporation of DNA at HH4 allows for screening of
DNA activity in early chick development. First embryos are harvested from the egg by
clearing albumin using the blunt end of forceps then a 2x2 cm Whatmans filter paper
with a 1cm hole punched in the center is placed onto the Vitelline membrane with the
embryo in the center of the punched hole. The filter paper is cut from the yolk and excess
yolk is removed with Hanks Buffered Salt Solution. The embryo is placed on a silicone
support with a 2mm deep well containing a 2 x 2 mm platinum cathodal electrode (see
Fig 10). Using a glass capillary pulled-needle, a mixture of the construct plasmid (1μg)
and Fas-green dye to visualize delivery is injected in the space between the vitelline
membrane and the excised embryo. The anodal electrode is held above the embryo by a
micromanipulator with a 3mm inter-electrodal space. HBSS is used between the electrode
and the embryo to ensure electrical conductivity. The reporter plasmids are driven into
the embryo by 5 pulses of 5 V for a duration of 50 ms at 100 ms intervals using a CUY21
electroporator (Protech International, Austin, Texas). Following electroporation embryos
are incubated on a yolk agar plate in a humidified chamber at 370C. Construct activity
measured as fluorescent GFP is visualized with fluorescent microscopy and imaged at 24
and 48hrs.
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Figure 2.2) Apparatus for Whole Embryo Electroporation at HH4
Upper panel, silicone support and micro-manipulators used for precise delivery of
plasmid and stable upper electrode placement. Lower panel, embryo on silicone support
showing needle with plasmid/phenol red marker at needle tip. The electrode is placed
over the embryo in contact with buffer solution.
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HH 10 EP was performed to determine construct efficacy in the brain. Embryos
were staged and stained with neutral red to facilitate removal of the vitelline membrane
surrounding the head and electroporation. DNA (1 μg) was injected into the neural tube
lumen and pushed cranially toward the tip of the anterior neural pore. Electrodes are
0.5mm in diameter and are placed on either side of the head approximately 4mm apart
delivering 3 pulses of 50 ms at 10 V at 100 ms intervals. Embryos are incubated and
imaged with fluorescent microscopy at 24 and 48 hours to determine construct activity.
Targeted regional electroporation at HH14 was directed to transfect the lateral
plate mesoderm thereby introducing DNA into the entire presumptive limb. Briefly, eggs
are windowed and embryos stained with neutral red to determine somite number. The
vitelline membrane overlying the limb is removed and a small slit cut on the yolk
membrane near the heart. Two platinum electrodes (0.3 mm diameter, at 2.5 mm
distance) are mounted on a micromanipulator and positioned parallel to the embryo. The
cathode is placed through the slit and into the yolk. Using a glass capillary pulled-needle,
a mixture of the regulatory-construct plasmid (2 μg/μL) and fas-green are injected into
the embryonic coelom underlying the right lateral plate mesoderm. The anode is placed
above the embryo and 3-5 drops of PBS are used to ensure conductivity. Electroporation
(EP) was performed with 3 pulses of 50 ms at 8 V at 100 ms intervals. Following surgery
embryos can be imaged for construct activity and/or incubated for 10 days allowing
formation of the presumptive skeletal structures. We utilized TREP to test the limb
dorsalization properties of an RCASBP(A) vector expressing hLmx1b. Overexpression
of our RCASBP-hLmx1b construct successfully produced feather buds on the ventral
limb surface.
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Experimental limb

Control limb

Ventral

Dorsa

Figure. 2.3) Dorsalization of the Chick Limb using the RCASBP-hLmx1b
Construct
The chick wing was electroporated at HH14 along the lateral plate mesoderm to
overexpress Lmx1b in the entire limb.

We also perform a focal limb electroporation technique using HH21/22 embryos.
The Vitelline membrane is removed around the limb and a small amount of fluid is
removed then limbs can be flipped to expose the ventral surface. A bolus of 1μl
containing 1 μg of DNA is injected into the limb mesoderm. Electrodes are placed on
either side of the limb with fluid placed on top to ensure conductivity. Focal
electroporation is performed with 3 pulses of 50 ms at 50 V at 100 ms. Below is an
example of our focal electroporation technique using the RCASBP-hLmx1b expressed on
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the ventral limb surface. Embryos were incubated for 48 hours and harvested to
performed hLmx1b expression WMISH.

Figure 2.4) Focal Electroporation of RCASBP-hLmx1b into the Ventral Wing
Mesoderm
Whole mount in situ hybridization probing for hLmx1b in the chick wing. Expression is
absent from the control limb and can be seen in the ventral mesoderm of the experimental
limb.
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Abstract
Lmx1b is a homeodomain transcription factor that regulates dorsal identity during
limb development. Lmx1b knockout (KO) mice develop distal ventral-ventral limbs.
Although induction of Lmx1b is linked to Wnt7a expression in the dorsal limb ectoderm,
the downstream targets of Lmx1b that accomplish limb dorsalization are unknown. To
identify genes targeted by Lmx1b, we compared gene arrays from Lmx1b KO and
wildtype mouse limbs during limb dorsalization, i.e., 11.5, 12.5, and 13.5 days post
coitum.
We identified 54 target genes differentially expressed in all three stages. Several
skeletal targets, including Emx2, Matrilin1 and Matrilin4, demonstrated a loss of scapular
expression in the Lmx1b KO mice, supporting a role for Lmx1b in scapula development.
Furthermore, the relative abundance of extracellular matrix-related soft tissue targets
regulated by Lmx1b, such as collagens and proteoglycans, suggests a mechanism which
includes changes in the extracellular matrix composition to accomplish limb
dorsalization.
Our study provides the most comprehensive characterization of genes regulated
by Lmx1b during limb development to-date and provides targets for further investigation.

Keywords:
Limb development, mouse, patterning, Lmx1b, microarray
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Introduction
The limb is a complex organ that requires unique multi-axis asymmetry for
function. The limb emerges from the lateral plate mesoderm as a bulge of
undifferentiated mesoderm covered by ectoderm. In the mouse model at 11.5 days post
coitum (dpc) the limb bud mesoderm is diffuse and relatively uniform. Centrally, the
mesoderm condenses to form cartilage anlagen and peripheral mesoderm condenses to
form tendon precursors. Joint segmentation begins as a zone of high cell density (an
interzone) within the mesodermal condensation (Craig, Bentley, & Archer, 1987;
Dalgleish, 1964). The joint capsule and associated ligaments and tendon attachments
develop from condensations surrounding the interzone regions (Mitrovic, 1978). This
process proceeds in a proximal-to-distal fashion. By 13.5 dpc, the skeletal elements,
joints, ligaments and tendon precursors of the stylopod (humerus/femur), zeugopod
(radius-ulna/tibia fibula) and autopod (hand/foot) are largely defined.
Development of the limb bud can be described along three axes. The proximaldistal axis depicts the progressive outgrowth of the three limb segments: stylopod,
zeugopod and autopod. The anterior-posterior axis defines the patterning of the digits
(e.g., from thumb to little finger) and zeugopod (e.g., radius and ulna). The dorsalventral axis delineates the extensor and flexor compartments of the limb. The limb has
marked asymmetry in structure and function along the dorsal-ventral axis despite being
composed of similar elements. This limb asymmetry is under the control of Lmx1b, a
dorsalizing homeodomain-containing transcription factor. Lmx1b knockout (KO) mice
(Chen, et al., 1998) display distal ventral-ventral morphology in the bone, muscle and
soft tissues. In humans, single allele mutation of LMX1B causes Nail Patella Syndrome
(NPS) (Dreyer et al., 1998) with incomplete dorsalization of extremities, i.e., loss of the
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patella, deficient nails, and joint malformations. However, limb-specific downstream
target genes of Lmx1b have yet to be clearly defined.
The molecular control of dorsalization is initiated by Wnt7a expression in the
limb bud ectoderm (Riddle, et al., 1995). Progressive expression of the En-1
transcription factor in the ventral ectoderm restricts Wnt7a to the dorsal ectoderm
(Cygan, et al., 1997; Loomis, et al., 1998). Secretion of dorsally-restricted Wnt7a into the
underlying mesoderm induces Lmx1b expression limited to the dorsal mesoderm (Vogel,
et al., 1995). During progressive joint and tendon formation (11.5dpc - 13.5dpc), the
expression of Lmx1b proximally decreases and becomes restricted to differentiated
tissues while retaining intense expression in the distal less-differentiated dorsal
mesoderm (Dreyer et al., 2004).
The restriction of Lmx1b to dorsal tendons and joints during differentiation
suggests a role in tendon/joint formation, but no direct link between Lmx1b and any
tendon- or joint-related genes have been described. In this report, we used microarray
analysis to identify differentially expressed genes during joint, ligament and tendon
formation in the presence (wildtype mice) or absence (Lmx1b KO mice) of Lmx1b.
Progressive stages were analyzed and compared in an effort to minimize stage-specific
differences and accentuate Lmx1b-specific targets. Our analysis identified genes
regulated by Lmx1b that are involved in asymmetric nerve, bone, joint, ligament, and
tendon formation during dorsalization.
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Materials and Methods
Lmx1b KO Mouse
Lmx1b knockout (KO) mice were a kind gift of Randy L. Johnson (Chen, et al.,
1998). Lmx1b homozygous mouse embryos were obtained by mating heterozygous male
mice with heterozygous female mice. We time-dated matings using noon on the day that
the vaginal plug was found as 0.5 days post coitum (dpc). At 11.5 and 12.5 dpc, embryos
were harvested and the limb buds with the limb girdles were isolated. Embryos at
13.5dpc were also harvested and their distal limb buds (zeugopods and autopods) were
isolated. Embryos were genotyped to confirm Lmx1b homozygosity (-/- or +/+).

Gene Expression Array
RNA from embryonic forelimbs and hindlimbs of wild type (WT) and Lmx1b KO
mice was harvested using the Rneasy Kit (Qiagen). RNA was pooled to decrease genetic
variability, i.e., six limbs at 11.5 dpc, three limbs at 12.5 dpc and six limbs at 13.5 dpc.
Duplicate samples were generated using different embryos for each stage and then
hybridized to the Affymetrix GeneChip® Mouse Genome 430 2.0 Array (UCI, Irvine,
CA). Microarray data was submitted to Gene Expression Omnibus and can be located
under series accession number GSE34732. The data was normalized using RMA and
analyzed using the Comprehensive R and Bioconductor based web service for microarray
data analysis (Rainer, Sanchez-Cabo, Stocker, Sturn, & Trajanoski, 2006). Genes
differentially expressed between WT and Lmx1b KO mice with pvalue >0.05 were not
considered significant and were not further analyzed.
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In order to enhance gene discovery, all genes with significant differential expression
were examined to compare expression differences at all three stages. Genes which
demonstrated a 2-fold change at any stage were considered for further analysis.

Validation by Real-time PCR
Complementary DNA (cDNA) was transcribed from limb mRNA at each stage using
both Lmx1b KO and WT mice. PCR products were sequenced to determine specificity
(Supplemental Data Table 2). Differential expression was determined by Real-time PCR
(Quantitative-PCR (Q-PCR)) measuring SYBR Green I fluorescence with the Roche
Lightcycler 2.0 and Roche-recommended reagents. Triplicate Lightcycler runs with
duplicate samples were compared to simultaneous PGK runs to normalize fold changes
between Lmx1b KO and WT expression. Gene targets were considered validated if QPCR data confirmed microarray data with at least a 2-fold change at any stage.

Whole Mount in situ Hybridization
Sense and antisense digoxigen-labeled RNA probes ranging from 600bp – 1000bp
were generated for each of the genes validated by Real-time PCR. Probes were sequenced
to ensure specificity (Supplemental Data Table 2). Aggrecan probe sequence was
generously provided by the Nancy Schwartz lab (Cortes, Baria, & Schwartz, 2009).
Lmx1b KO and WT mouse embryos were harvested at 12.5 dpc and fixed overnight in
MEMFA (0.1M MOPS, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde). Whole mount
in situ hybridization was performed as described (Yamada, Szendro, Prokscha, Schwartz,
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& Eichele, 1999) with each probe hybridized at 60°C, and embryos were washed post
hybridization at 65°C.
Results
Determination of Candidate Genes by Comparative Microarray
In an effort to identify targets of Lmx1b involved in limb dorsalization, we isolated
limb bud tissue with robust Lmx1b expression between 11.5 days post coitum (dpc) and
13.5dpc. At 11.5 dpc, expression of Lmx1b is throughout the dorsal limb bud mesoderm
(Fig 3.1B). Thus, we harvested the entire limb bud as depicted in Fig 3.1A. The tissue
harvested includes presumptive limb girdle elements (e.g., scapula) and tissue that will
become all three segments of the limb (stylopod, zeugopod and autopod). Expression of
Lmx1b at 12.5 dpc begins to localize to the condensing tendons proximally, while in
distal less-differentiated dorsal mesenchyme, expression remains diffuse (Dreyer, et al.,
2004). At this stage, we also harvested the entire limb including limb girdle elements
(Fig.3.1A). Lmx1b expression at 13.5 dpc wanes proximally but remains strong in the
autopod (Fig.3.1B). Therefore, the autopod was harvested at 13.5 dpc to coincide with
strong Lmx1b expression (Fig.3.1A). In order to diminish biologic variability and
enhance Lmx1b-associated changes, RNA was pooled from several different
embryos/litters. Genes with significant (p<0.05) differential expression were included in
our data for this study.
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Figure 3.1) Depiction of Methods
A.) Depiction of the three developmental stages analyzed by microarray. Presumptive
structures are color-coded at each embryonic stage depicting the progressive
differentiation of the limb. Dashed red lines are drawn to illustrate the limb tissue
harvested for gene array experiments. (dpc- days post coitum) B) Section in situ
hybridization for Lmx1b at 11.5 dpc (2) with expression pseudocolored red demonstrating
restricted dorsal expression. By 13.5 dpc (4), proximal expression of Lmx1b is less
intense and localized to condensing musculo-tendonous tissue; distal Lmx1b expression
remains diffuse in the dorsal mesoderm. H&E of corresponding limbs show the amount
of relative tissue differentiation at each stage(1,2). (musc- muscle) (cart- cartilage)
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Figure 3.2) Analysis of Microarray Data
A.) The number of genes with significant (p < 0.05) differential expression between WT
and Lmx1b KO microarray analyses for each stage. The last column identifies the subset
of genes differentially expressed in all three stages. B.) Graphical representation of
ingenuity pathway assistant (IPA) analysis that identifies developmental processes and
system networks containing the genes that are differentially expressed at each stage. The
relative significance determined by IPA defined parameters is listed on the y-axis. The
number of genes in each network is listed at the top of each bar. The P value < 0.05 is
denoted by the orange threshold line.

At 11.5 dpc, we identified 331 genes that were up-regulated in the presence of
Lmx1b, while 368 genes were down-regulated. Lmx1b up-regulated the expression of
303 genes and down-regulated 1051 genes at 12.5 dpc. By 13.5 dpc, Lmx1b up-regulated
942 genes, and down-regulated 423 genes (Fig 3.2A).
To identify functionally relevant developmental pathways or networks used by
Lmx1b, we analyzed our dataset with the Ingenuity Pathway Assistant (IPA) software
(Fig 3.2B). When a comparison analysis is performed across stages, the data cluster into
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several networks affected by Lmx1b. These include skeletal, connective tissue and
nervous system developmental networks which correlate with morphology disrupted in
the Lmx1b knockout (KO) mouse. Many of the targets discovered at individual stages
may represent stage specific changes. In order to enrich genes downstream of Lmx1b
during limb dorsalization, we identified genes with similar changes in expression for all
three stages. We discovered 45 up-regulated genes and 9 down-regulated genes across all
three stages. These genes were considered Lmx1b targets. Similar studies by Kania et
al., used a 1.4-fold change; we chose a more stringent criterion since we have a larger
data set incorporating several embryonic stages. For further analysis, we required
candidate genes to have at least a 2-fold change at one or more stages. In addition, we
selected genes that we suspected to be involved with limb development pathways. Table
1 lists the 23 genes which met this criterion, along with the fold change demonstrated at
each stage.
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Table 3.1) Partial list of genes from microarray analysis regulated by Lmx1b
during all three experimental stages
A partial list of up and down-regulated genes identified by gene array across all three
stages. Gene symbols and descriptions are listed along with the fold change at each stage.
All data points listed in the table have a p value of < 0.05. Genes included in this partial
list had a two fold change at one or more stages by gene array analysis. The final column
indicates Q-PCR validation of this inclusion criteria.
UP-REGULATED
Description

Symbol

Empty spiracles homolog 2
(Drosophila)
Emx2
Keratocan
Kera
Lumican
Lum
Decorin
Dcn
Aggrecan 1
Agc1
Matrilin 1, cartilage matrix protein
1
Matn1
Matrilin 4
Matn4
Growth differentiation factor 5
Gdf5
Procollagen, type IX, alpha 3
Col9a3
Procollagen, type XI, alpha 2
Col11a2
Cerebellin 2 precursor protein
Cbln2
Lysyl oxidase
Lox
Epidermal growth factorcontaining fibulin-like
extracellular matrix protein 1
Efemp1
Noggin
Nog
Leukocyte cell derived chemotaxin
1
Lect1
Scinderin
Scin
Apolipoprotein D
Apod
Fam
MGC99845
Retinoic acid receptor, beta
Rarb

11.5 FC 12.5 FC 13.5 FC Validated
2.57
3.56
2.56
1.43
1.53

5.30
13.40
3.67
2.10
1.88

2.21
7.82
2.33
2.57
2.02

Yes
Yes
Yes
Yes
Yes

2.09
1.41
1.61
1.51
1.37
1.54
1.59

3.07
1.60
2.10
1.53
1.57
2.45
2.45

2.36
2.03
2.10
2.07
2.02
2.21
1.45

Yes
Yes
Yes
No
Yes
Yes
Yes

1.46
1.46

1.68
1.87

2.37
2.30

No
Yes

2.69
1.41
1.70
1.45
1.51

2.44
2.22
2.97
1.60
2.04

1.81
2.48
2.28
2.70
1.45

Yes
Yes
Yes
Yes
No

DOWN-REGULATED
Regulatory factor X, 4
RIKEN cDNA 1700109F18 gene
Myeloid ecotropic viral integration
site 1
AF4/FMR2 family, member 3

Rfx4
Rik

1.99
1.31

2.73
2.49

1.60
2.09

Yes
No

Meis1
Aff3

1.31
1.40

1.41
2.02

2.24
1.43

No
Yes
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Validation of Candidate Lmx1b Target Genes by Real-time PCR
Candidate genes derived by microarray analysis were confirmed by Real-time
PCR (Q-PCR) using SYBR green fluorescence. Q-PCR data met the previously
described 2-fold change criteria for 18 candidate genes (Fig 3.3). Four genes (denoted in
red) fell below our threshold and were not examined further. The fold-change at 12.5 dpc
was greater than at other stages for most of the Lmx1b related targets. This finding
suggests that 12.5 dpc is a crucial time during dorsalization, with Lmx1b exerting its
greatest influence on gene targets. Thus, we examined the expression patterns of
candidate genes in the WT and Lmx1b mutant mice at 12.5 dpc.

Figure 3.3) Graphical representation of Real-time PCR (Q-PCR)
The fold change of each gene was measured at each stage; a 2-fold threshold is denoted
by a blue line. Q-PCR validated microarray data for genes shown in black type. Genes
denoted in red failed to meet validation criteria. The greatest fold changes are
consistently seen at stage 12.5 dpc, therefore this stage was used for in situ hybridization
analysis. * Col9a3 produced a 1.9-fold change at 12.5 dpc. Since several other collagen
related targets were also validated, Col9a3 was analyzed further.
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Confirmation of Candidate Lmx1b Target Genes by Whole Mount in
situ Hybridization (WMISH)
WMISH was utilized to determine differential expression for 19 genes. Their
expression patterns are briefly described below and illustrated in figures 3.4, 3.5, and 3.6,
along with the expression pattern of Lmx1b (Fig 3.4 A,a, & A’,a’).
Apolipoprotein D (ApoD) is a carrier glycoprotein that is part of the lipocalin
superfamily. In humans, ApoD is a minor component of plasma high density
lipoproteins. Apod has been reported as a potential downstream target of Lmx1b with
dorsal ectodermal expression of ApoD demonstrated at 13.5 dpc (Gu & Kania, 2010). We
found expression of ApoD proximally in the dorsal limb mesoderm (Figure 3.4 B,b, &
B’,b’) and accentuated at the anterior presumptive wrist boundary in the presence of
Lmx1b at 12.5 dpc (Fig. 3.4 B, white arrow). We also confirmed the previously reported
expression within the dorsal ectoderm at 13.5 dpc (data not shown), indicating a stagespecific shift in ApoD expression.
We found Empty spiracles 2 (Emx2), a transcription factor encoding gene linked
to the formation of the scapula (a dorsal limb girdle structure), to be expressed diffusely
within the dorsal limb girdle at 12.5 dpc (Fig 3.4 C,c). Emx2 expression also extends
from the limb girdle out into the dorsal autopod mesoderm. In Lmx1b KO mice,
expression of Emx2 is absent in both the scapular and dorsal limb mesoderm (Fig 3.4
C’,c’).
Cerebellin 2 (Cbln2) is a cerebellum-specific, membrane-associated
hexadecapeptide derived from Cerebellin 1. Leukocyte cell-derived chemotaxin 1 (Lect1)
is a cartilage-specific glycoprotein also known as Chondromodulin I. Interestingly in our
WMISH Cbln2 and Lect1 both exhibit focal points of intense dorsal expression (Fig 3.4
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D,d, D’,d’, E,e, & E’,e’). Cbln2 displays focal anterior and posterior limb girdle
expression in the dorsal mesoderm (Fig 3.4 D white arrows). There is also concentrated
expression overlying the proximal zeugopod (black arrowhead) and two discrete zones of
dorsal expression at the zeugopod-autopod boundary (white arrowheads). Lect1 has
strong focal dorsal expression over the stylopod and a pattern similar to Cbln2 expression
along the zeugopod-autopod boundary (Fig 3.4 E). The limbs of Lmx1b KO mice show
near absence of Cbln2 and Lect1 expression at all of these sites (Fig 3.4 D’d’ and E’,e’
respectively).
Several genes up-regulated by Lmx1b localize to the developing skeleton. Growth
differentiation factor 5 (Gdf5) is a member of the TGF-beta superfamily of secreted
growth factors. Gdf5 expression in WT limbs localizes to developing joints, interdigital
regions and dorsal mesoderm along the zeugopod (Fig 3.4 F,f), and is prominent in the
developing elbow joint (Fig 3.4 F, white arrow). In the Lmx1b KO mouse limb, Gdf5
expression is absent from the area associated with the olecranon and reduced within
interdigital regions (Fig 3.4 F’). Matrilin 1 (Matn1) and Matrilin 4 (Matn4) are cartilage
matrix proteins. Aggrecan (Agc) is a chondroitin sulfate proteoglycan, Agc, Matn1, and
Matn4 expression surrounds condensing cartilage in the limb and the scapula at 12.5 dpc
(Fig 3.4 G,g,H,h,I,i respectively). Interestingly, the scapula lacks Agc, Matn1, and Matn4
in Lmx1b KO mice (Fig 3.4 G’g’,H’,h’,I’,I’ respectively). Agc and Matn1 is also absent
in the ulnar anlagen, while Matn4 in the ulnar anlagen is absent distally. Additional
skeleton-related genes identified by our gene array show symmetrical expression along
the dorsal-ventral axis and include Noggin, Scinderin, Collagen9a3 and Collagen11a2.
(Fig 3.5). These genes display decreased expression in Lmx1b KO mice.
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Lysyl oxidase 1 (Lox) encodes a connective tissue-related enzyme that is
expressed strongly in the dorsal mesoderm from the limb girdle to the distal zeugopod
(Fig 3.4 J,j). Lox in the Lmx1b KO mouse is greatly reduced (Fig 3.4 J’,j’). A cluster of
connective tissue-related proteoglycans was also identified in our gene array as potential
candidates: Keratocan (Kera), Lumican (Lum), and Decorin (Dec). Kera is expressed
intensely in the dorsal zeugopod mesoderm (Fig 3.4 K,k) and is undetectable in Lmx1b
KO limbs (Fig 3.4 K’,k’). Lum and Dec demonstrate strong dorsal mesodermal
expression with very light staining of the proximal ventral mesoderm in WT limbs (Fig
3.4 L,l,M,m). Lmx1b KO limbs display greatly reduced dorsal expression of Lum and
Dec; the residual staining is symmetrical and consistent with the light ventral expression
seen in WT limbs (Fig 3.4 L’,l’,M’,m’).
The up-regulated target Family with sequence similarity 196, member B
(Fam196b) is a predicted gene which was not detectable by WMISH.
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Figure 3.4) Whole Mount in situ Hybridization of Targets Up-regulated by Lmx1b
WMISH for Q-PCR validated up-regulated genes at 12.5 dpc. Cartoon provides
orientation for pictures, line along AP axis depicts cut performed for dorsoventral
pictures. Dorsal views along with cross sections are shown for each gene. Expression
patterns for each gene are as follows: Capital letter (e.g., A) denotes expression in WT
limbs along the dorsal surface, capital letter with apostrophe (e.g., A’) denotes expression
in Lmx1b KO limbs along the dorsal surface. Small letter (e.g., a) marks WT limb
sections while small letter with apostrophe (e.g., a’) indicates KO limb sections. B, white
arrow indicates anterior Apod expression. D Cbln expression in the autopod (white
arrowhead), zeugopod (black arrowhead), and proximal/stylopod (white arrows). F, Gdf5
in the olecranon (white arrow). H and I, black arrows both indicate scapular stain for
Matn1 and Matn4, respectively.
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Figure 3.5) Whole Mount in situ Hybridization of Skeletal Targets Up-regulated by
Lmx1b
Expression patterns for each skeletal related gene at 12.5 dpc are as follows. Capital letter
(e.g., A) denotes WT expression along the dorsal surface. Capital letter with apostrophe
(e.g., A’) denotes WT ventral expression while (A”) denotes cut sections. Small letter
(e.g., a) marks WT limb sections while small letter with apostrophe (e.g., a’) indicates
Lmx1b KO limb sections. All skeletal genes show a decrease in expression in the Lmx1b
KO limb.

The two additional transcription factors that were identified by our gene array
were down regulated. Regulatory factor X,4 (Rfx4) is a winged helix transcription factor,
which is expressed in the ventral limb mesoderm proximally and anteriorly (Fig 3.6
A,A’,A’’white arrowheads ), and is duplicated in the dorsal mesoderm of the Lmx1b
mutant (Fig 3.6 B,B’B’’white arrowheads). The nuclear transcription factor AF4/FMR2
family, member 3 (Aff3) shows broad ventral expression within the presumptive soft
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tissue of the zeugopod and autopod, surrounding the condensing cartilage and extending
to the ectoderm, while on the dorsal aspect, the subectodermal expression is lacking (Fig
3.6 C,C’,C’’,c’’red line). Lmx1b KO limbs reveal broad symmetrical Aff3 expression
patterns along the dorsal and ventral mesoderm (Fig 3.6 D,D’,D’’,d’’).

Figure 3.6) Whole Mount in situ Hybridization of Targets Down-regulated by
Lmx1b
WMISH for Q-PCR validated down-regulated genes at 12.5 dpc, cut sections performed
as illustrated by cartoon in Fig.4. Rfx4 is expressed dorsally (A) and ventrally (A’, white
arrowhead; A”, cut section, white arrowhead) WT limb. In the Lmx1b KO limb, Rfx4 is
expressed dorsally (B) and ventrally (B’). A cut section shows duplicated expression
(B”, white arrowhead). C and C’ show dorsal and ventral Aff3 expression in WT limb,
respectively. C” displays enhanced ventral Aff3 expression, magnification area denoted
by the white box demonstrates absence of Aff3 in the dorsal subectodermal mesoderm
(red line). D and D’ show dorsal and ventral expression of Aff3 in the Lmx1b KO limb,
respectively. D” magnified in d’’, Aff3 is enhanced both dorsally and ventrally limb.
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Discussion
Lmx1b is a homeodomain transcription factor known to be necessary and
sufficient for dorsalizing distal limb structures including skeletal elements, nerves,
tendons and ligaments. Loss of Lmx1b expression in Lmx1b KO mice causes scapular
hypoplasia, distal ulnar hypoplasia, and loss of soft tissue dorsalization, i.e., symmetrical
ventral-ventral or flexor-flexor ligaments, tendons and muscles (Chen & Johnson, 2002).
Retroviral mediated overexpression of LMX1B in limb mesoderm generates a dorsaldorsal distal phenotype (Vogel, et al., 1995). Therefore, it is expected that Lmx1b
regulates many diverse targets during limb dorsalization. Supporting this concept, our
microarray analysis revealed clusters of target genes associated with bone, connective
tissue, and nerve development.

Lmx1b Genes Associated With Skeletal Development
Our microarray data included several skeletal targets: Noggin, Growth
differentiation factor 5 (Gdf5), Aggrecan (Agc), Scinderin, Collagen9a3, Collagen11a2,
Matrilin1 (Matn1) and Matrilin4 (Matn4). Of these targets, Gdf5, Agc, Matn1 and Matn4
demonstrate asymmetric expression in normal mice that is disrupted in Lmx1b KO mice
(Fig 3.4 F’,G’,H’,I’).
Gdf5 is a regulator of joint and cartilage formation (Buxton, Edwards, Archer, &
Francis-West, 2001). In the 12.5 dpc limb, Gdf5 is expressed within the developing joints
and interdigital spaces (Fig 3.4 F). Notably, the developing elbow joint is an asymmetric
structure with a prominent dorsal joint interface. Correspondingly, Gdf5 expression
includes a strip of dorsal mesoderm (Fig 3.4 F,white arrow). In Lmx1b KO embryos, this
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expression is absent, consistent with our microarray and Real-time PCR analysis. In a
previous report, no difference in Gdf5 expression was seen in autopod joints between
normal and Lmx1b KO mice, however the elbow was not examined (Dreyer, et al., 2004).
Although Lmx1b may regulate Gdf5 expression, Gdf5 KO mice do not present with
obvious dorsoventral abnormalities; instead, loss of Gdf5 in mice and humans causes
shortened limbs with abnormal joint formation and ossification of digits (Storm et al.,
1994). Lmx1b plays a role in elbow development, since over 90% of patients with
haploinsufficiency present with elbow dysplasia (E. M. Bongers, et al., 2002). Thus, the
loss of Gdf5 expression in Lmx1b KO mice may signify a contribution to or reflection of
deficient elbow dorsalization.
Agc is a highly expressed structural proteoglycan associated with cartilage
development and maintenance. In the cartilage matrix deficiency mouse (CMD), wherein
Agc is spontaneously/naturally deleted, there is marked limb hypoplasia with no apparent
dorsal-ventral limb axis abnormalities (Watanabe & Yamada, 2002). However, in our
review of the published data, Agc deficient mice do appear to have more pronounced
ulnar hypoplasia with ulnar deviation at the wrist. Lmx1b KO mice show a loss of Agc
expression within the presumptive ulna (Fig 3.4 G’). This deficiency in Agc expression in
the posterior cartilage anlagen may contribute to the ulnar hypoplasia seen in the Lmx1b
KO mouse.
Matrilin (Matn) genes exhibit overlapping expression patterns; in particular
Matn1 and Matn4 are expressed in cartilaginous tissues where they bind collagen and
proteoglycans to aid in skeletogenesis. Similar to Agc in the Lmx1b KO limb, Matn1
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expression is lacking in the presumptive ulna (Fig 3.4 H’). In contrast, Matn4 expression
is present within the proximal ulna anlagen, but is absent distally (Fig 3.4 I’).
Ulna formation is under the control of Sonic Hedgehog (Shh) (Ros et al., 2003).
The differential expression patterns of Agc, Matn1 and Matn4 in response to Lmx1b
suggest that posterior cartilage proteoglycan regulation may be a collective target of
Lmx1b and Shh. Furthermore, these findings support the concept that Lmx1b may work
in concert with other patterning factors along different axes, such as Shh, to generate
asymmetrical structures.

Lmx1b Regulated Genes Associated With Connective Tissue
Development
A large second group of target genes uncovered by our analysis express within the
dorsal limb mesoderm and, therefore, may be regulated by Lmx1b to pattern dorsal soft
tissues. These include: Empty spiracles homolog 2 (Emx2), Apolipoprotein D (ApoD),
Lysyl oxidase (Lox), Keratocan (Kera), Lumican (Lum), and Decorin (Dec).
Emx2 expression extends along the dorsal mesoderm of the zeugopod, continuing
distally into the autopod and digits (Fig 3.4 C). This expression is absent in Lmx1b KO
limbs (Fig 3.4 C’). Overexpression of Emx2 in the chick model induced a single posterior
or mirrored digit on the anterior border (Pröls et al., 2004). A role for Lmx1b in the
integration of Shh signals has been suggested by Tzchori and co-workers (Tzchori et al.,
2009), although no disruption of Shh signaling is evident in Lmx1b KO limbs (Chen, et
al., 1998). As suggested for posterior proteoglycans, it is possible that Lmx1b and Shh
work in combination to also regulate digit-specific Emx2 activity. Alternatively, Emx2
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and Shh could work in concert to establish dorsal digit identity. Irrespectively,
overexpression of Emx2 in the limb appears to mimic or induce ectopic Shh expression.
ApoD is a multi-ligand, multi-functional transporter (Rassart et al., 2000). The
expression of ApoD at 13.5 dpc has been reported in the dorsal limb ectoderm (Gu &
Kania, 2010). We confirmed dorsal ectoderm expression at 13.5 dpc; however, at 12.5
dpc, we found ApoD expression in the anterior dorsal mesoderm (Fig 3.4 B). With its
stage-specific shift from dorsal limb mesoderm to ectoderm and loss of expression in
Lmx1b KO limbs, it is unclear what role ApoD might play in limb development since
ApoD KO mice have no reported limb abnormalities (Ganfornina et al., 2008).
Lox is a soft tissue associated target involved in collagen formation/maturation.
Lox expression is broad in the proximal dorsal mesoderm extending out into the
zeugopod (Fig 3.4 J). Lox expression at 12.5dpc overlaps Lmx1b expression in the
zeugopod; however this expression is absent in the Lmx1b KO limb (Fig 3.4 J’). The role
of this differential expression in response to Lmx1b is unclear. Since Lox is a copper
binding enzyme involved in crosslinking collagen and elastin (Kagan & Trackman,
1991), it is possible that dorsal tendons/ligaments in mice have a composition of elastin
and collagen that differs from ventral tendons and/or ligaments.
Kera, Dec, and Lum are proteoglycans associated with connective tissue
development. Dec and Lum are associated with collagen fibrillogenesis and degeneration
of the eye, skin and tendons. The ability to slow, but not to stop, the process of collagen
formation allows for the homogeneous spacing between collagen fibrils during
development. Not surprisingly, Dec KO (Danielson et al., 1997) and Lum KO mice
(Chakravarti et al., 1998) present with irregularly spaced collagen, which causes weak or
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abnormal connective tissue i.e. weak tendons with irregular attachment sites, and skin
fragility. Lmx1b KO mice display a marked reduction of Dec and Lum expression in the
distal dorsal mesoderm with limited expression remaining in the proximal ventral and
dorsal mesoderm (Fig 3.4 L,M). Kera has been studied in the embryonic eye and adult
tendon where it is utilized for collagen fibril development and maintenance (Conrad &
Conrad, 2003; Liu, Birk, Hassell, Kane, & Kao, 2003). Kera expression in the Lmx1b KO
was undetectable (Fig 3.4 K’). In addition, expression of Collagen9a3 and Collagen11a2
(Fig 3.5 C,D) is reduced in Lmx1b KO limbs(Fig 3.5 C’,D’). The collective differential
expressions suggest that Lmx1b plays an active role in collagen formation and
maintenance, which may, in part, confer the dorsal character of these structures.

Lmx1b Regulated Genes Associated With Neuronal Development and
Angiogenesis
Cerebellin 2 (Cbln2) and Leukocyte cell-derived chemotaxin 1 (Lect) demonstrate
a strikingly similar focal pattern of expression of the dorsal zeugopod and autopod (Fig
3.4 D,E), which is greatly reduced in the Lmx1b KO (Fig 3.4 D’,E’). Lmx1b guides the
initial branching and subsequent trajectory of dorsal motor axons (Kania, Johnson, &
Jessell, 2000). Interestingly, Cbln2 is abundant in the embryonic brain (Miura, Iijima,
Yuzaki, & Watanabe, 2006) and has been linked to connectivity in sensory neurons
(Reiner, Yang, Cagle, & Honig). Therefore, Lmx1b may work in conjunction with
localized dorsal Cbln2 expression to guide motor axon trajectory and branching. Lect
functions as an inhibitor of angiogenesis in the growth plate (Shukunami, Iyama, Inoue,
& Hiraki, 1999). Lect in the dorsal limb may assist Lmx1b in pattering blood vessels by
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restricting vasculogenesis of targeted locations associated with innervation and joint
formation.

Lmx1b Regulated Genes Associated With the Developing Scapula
The scapula, a component of the limb girdle, also develops as a dorsal structure.
Scapular development is a complex process. Signals from the lateral plate mesoderm
pattern the head of the scapula while Hox genes from somites create a segmental pattern
along the blade (Huang, Christ, & Patel, 2006; Huang, Zhi, Patel, Wilting, & Christ,
2000). Several knockout (KO) mouse models display varying degrees of scapular
aplasia. Emx2 (Pellegrini, Pantano, Fumi, Lucchini, & Forabosco, 2001) and Wntβcatenin (Hill, Taketo, Birchmeier, & Hartmann, 2006) KO mice display a complete loss
of the scapula, while Pax1 KO mice develop hypoplastic scapulae lacking the acromion
(Wallin et al., 1994). Tbx15 KO mice develop a foramen in the blade (Singh et al.,
2005), Alx3 KO and Cart1 KOs (Brouwer, ten Berge, Wiegerinck, & Meijlink, 2003)
reduce the rostral blade. Despite these mechanistic insights, a comprehensive list of
genes and how they interact during scapula formation remains unclear. Expression of
several genes discovered in our study localize to the developing scapula in normal mice.
Other than Emx2, the targets identified in our analyses have not previously been
associated with scapular formation. Agc, Lum, Dec, and Lox show a reduction of
scapular expression in Lmx1b KO mice (Fig 3.4 C’,G’,L’,M’). Emx2, Matn1, and Matn4
exhibit a striking loss of scapular expression (Fig 3.4 H’,I’). Since Lmx1b KO mice have
hypoplastic scapulae, we suggest Lmx1b works in concert with these collective targets to
augment scapular development.
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Genes Down-Regulated by Lmx1b During Limb Development
We discovered two genes down-regulated by Lmx1b in the dorsal limb bud.
Regulatory factor X, 4 (Rfx4) encodes for a transcription factor and has proximal anterior
expression in the ventral mesoderm (Fig 3.6 A’). This localized expression is duplicated
in the Lmx1b KO limb (Fig 3.6 B’’). Rfx transcription factors have been associated with
CNS development and may direct proximal nerve migration in the limb. A recent report
found that an intraflagellar transport protein, ift172, is a target of Rfx4 regulation, and in
a spontaneous mouse mutation, disrupted Shh and Gli signaling in the brain and spinal
cord (Ashique et al., 2009). Rfx4 expression was also observed in the limb, but no
skeletal abnormalities were reported (Ashique, et al., 2009). Soft tissue or nerve
patterning, however, was not examined. Thus, it is unclear what role this gene and the
regulation of cilia may have on dorsal-ventral patterning.
AF4/FMR2 family, member 3 (Aff3) is expressed in both the dorsal and ventral
mesoderm but has broader ventral expression during normal mouse limb development
that includes the subectodermal mesoderm (Fig 3.6 C’’,c’’). In the Lmx1b KO mouse,
Aff3 expression is equally accentuated in both the dorsal and ventral mesoderm (Fig 3.6
D’’,d’’). Aff3 was initially discovered in association with lymphoid tissue (Ma & Staudt,
1996), a more recent limb study detected expression at 11.5dpc and 13.5 dpc (Gyurján,
Sonderegger, Naef, & Duboule, 2011). The presence of Aff3 within the developing limb
and Q-PCR detected down-regulation by Lmx1b, suggests a role for Aff3 in dorsoventral
patterning.
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Summary
Previous studies have performed microarray analysis to discover downstream
Lmx1b targets. Krawchuk and Kania (2008) used proximal WT and Lmx1b KO 11.5 dpc
hindlimb tissue. Keratocan was the only target discovered coincident with our study;
however, Keratocan was considered “not significant or inconclusive”. Our data and data
from others (Randy Johnson, personal communication) find Keratocan significantly
elevated in comparative WT and Lmx1b KO mouse limb gene arrays. We propose
Keratocan is a significant Lmx1b target important to dorsal tendon formation. A second
microarray analysis was also published using 13.5 dpc limbs (Gu & Kania, 2010;
Krawchuk & Kania, 2008). This report revealed ApoD as a downstream target and Cbln2
as a “target of interest”. These two genes were also detected by our microarray study,
supporting their role as Lmx1b targets.
The persistent asymmetrical elevation of a cluster of proteoglycans during limb
dorsalization is a noteworthy discovery from our data and may provide clues to the
mechanical mechanism of dorsal morphogenesis. Kurpios and co-workers recently
demonstrated differential proteoglycan content within left and right dorsal mesentery that
caused asymmetric cell density, and the initiation of directional gut rotation (Kurpios et
al., 2008). Thus, one mechanism Lmx1b may use to orchestrate dorsalization is the
regulation of proteoglycans that modulate cell shape, density and migration.
Our multi-stage microarray data expands previous investigations to include
skeletal, connective tissue, neuronal, and angiogenic targets regulated by Lmx1b during
limb dorsalization. Several of these genes exhibit the Lmx1b binding site as described by
Morello and coworkers (Morello, et al., 2001), suggesting direct Lmx1b regulation.
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Although Lmx1b is necessary and sufficient to accomplish distal limb dorsalization
(Chen, et al., 1998), many of the genes in our data sets demonstrate a basal ventral
expression. This finding supports the concept of Lmx1b functioning as a selector
transcription factor in a multi-factor regulatory network as recently suggested by Qui and
coworkers (Qiu, et al., 2009).
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Supplemental Tables
Table 3.2) Genes Common to all three arrays (11.5,12.5, and 13.5 dpc). Positive fold
change values indicate genes up-regulated by Lmx1b, negative fold change denotes genes
down-regulated by Lmx1b. Genes shaded in grey were also analyzed with whole mount
in situ hybridization.
Description
Predicted gene
Keratocan
Empty spiracles
homolog 2
(Drosophila)
SLIT and NTRKlike family,
member 1
Lumican
DEAD (Asp-GluAla-Asp)
Matrilin 1,
cartilage matrix
protein 1

Symbol

11.5 FC
15.63

12.5 FC
5.68

13.5 FC
3.71

Kera

GenBank
AW493322
NM_00843
8

3.56

13.40

7.82

Emx2

BG072869

2.57

5.30

2.21

Slitrk1
Lum

AK014285
AK014312

1.44
2.56

5.02
3.67

2.17
2.33

Ddx3y

AA210261

1.49

4.97

1.57

2.09

3.07

2.36

1.70

2.97

2.28

2.69

2.44

1.81

BQ175551
NM_00913
2

1.54

2.45

2.21

1.41

2.22

2.48

BM118381
NM_00783
3

2.10

2.22

1.79

1.43

2.10

2.57

1.61
1.45

2.10
1.60

2.10
2.70

1.46

1.87

2.30

1.46

1.68

2.37

Apolipoprotein D
Leukocyte cell
derived
chemotaxin 1
Cerebellin 2
precursor protein

Apod

NM_01076
9
NM_00747
0

Lect1

NM_01070
1

Scinderin
Neuronal growth
regulator 1

Scin

Matn1

Cbln2

Negr1

Decorin
Growth
differentiation
factor 5

Dcn

Noggin
Epidermal growth
factor

Nog

NM_00810
9
BB020678
NM_00871
1

Efemp1

BC023060

Gdf5
MGC99845
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Lysyl oxidase

Lox

Aggrecan 1
Glycoprotein m6a
Unc-5 homolog D
(C. elegans)
Parathyroid
hormone-like
peptide
RIKEN cDNA
E330013P04 gene
Pentraxin related
gene
proCollagen, type
IX, alpha 3
Potassium
voltage-gated
channel
Matrilin 4
3'Phosphoadenosin
e 5'phosphosulfate
synthase 2
Guanylate cyclase
1, soluble, alpha 3
RIKEN cDNA
C030026M15
gene
Retinoic acid
receptor, beta
RIKEN cDNA
9430023B20 gene
proCollagen, type
XI, alpha 2
cDNA sequence
BC023892
proCollagen, type
XIV, alpha 1
RIKEN cDNA
5133401H06 gene
RIKEN cDNA
3110032G18 gene
Dystrophin,
muscular

1.59

2.45

1.45

Agc1
Gpm6a

M65143
NM_00742
4
BB348674

1.53
1.51

1.88
1.44

2.02
2.46

Unc5d

BB525782

1.31

2.13

1.86

Pthlh

NM_00897
0

1.76

1.83

1.67

E330013P04Rik

1.74

1.76

1.75

Ptx3

BG069958
NM_00898
7

1.61

1.93

1.57

Col9a3

BG074456

1.51

1.53

2.07

Kcnab1

1.31

2.16

1.62

Matn4

AK015412
NM_01359
2

1.41

1.60

2.03

Papss2

BF780807

1.45

1.64

1.95

Gucy1a3

BG072799

1.79

1.57

1.66

C030026M15Ri
k

BB742957

1.31

2.31

1.38

Rarb

BB266455

1.51

2.04

1.45

9430023B20Rik

BB021019

1.75

1.62

1.62

Col11a2

AV242706

1.37

1.57

2.02

BC023892

BE687858

1.34

1.90

1.70

Col14a1

AJ131395

1.44

1.94

1.47

5133401H06Rik

AK017223

1.47

1.47

1.85

3110032G18Rik

AK014112
NM_00786
8

1.45

1.57

1.69

1.70

1.57

1.37

Dmd
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dystrophy
Transmembrane
and coiled coil
domains 3
proCollagen, type
XI, alpha 1
Disabled homolog
1 (Drosophila)
RIKEN cDNA
3110032G18 gene
Cerebral
endothelial cell
adhesion
molecule 1
Tenascin C
Cadherin 10

Regulatory factor
X, 4
RIKEN cDNA
1700109F18 gene
Myeloid ecotropic
viral integration
site 1
AF4/FMR2
family, member 3
BG068672
(GenBank)
Corticotropin
releasing
hormone binding
protein
Fusion derived
malignant
liposarcoma
Myeloid ecotropic
viral integration
site-related gene 1
Odd Oz/ten-m
homolog 4
(Drosophila)

Tmcc3

1.36

1.77

1.41

Col11a1

BB711990
NM_00772
9

1.36

1.41

1.74

Dab1

BB429377

1.36

1.43

1.66

3110032G18Rik

BB458543

1.32

1.48

1.64

Ceecam1

1.38

1.38

1.64

Tnc
Cdh10

AV323203
NM_01160
7
AF183946

1.32
1.47

1.60
1.44

1.48
1.47

Rfx4

AV255458

-1.99

-2.73

-1.60

Rik

BB421876

-1.31

-2.49

-2.09

Meis1

BB055155

-1.31

-1.41

-2.24

Aff3

BM239026

-1.40

-2.02

-1.43

BG068672

-1.52

-1.77

-1.52

Crhbp

AI854101

-1.36

-1.40

-1.83

Fus

BE985138

-1.59

-1.48

-1.46

Mrg1

BM124348

-1.34

-1.44

-1.73

Odz4

BB046190

-1.37

-1.38

-1.42
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Table 3.3) Primer Sequences for qPCR and WMISH Probe Generation, primers are listed
in the 5’ to 3’ orientation.
Primer sequences
Gene
Description
Keratocan

GenBank
NM_008438

Leukocyte cell
derived
chemotaxin 1

NM_010701

Empty spiracles
homolog 2
(Drosophila)
Lumican

BG072869
AK014312

Matrilin 1,
cartilage matrix
protein 1

NM_010769

Apolipoprotein
D

NM_007470

Growth
differentiation
factor 5
Lysyl oxidase

NM_008109
M65143

Cerebellin 2
precursor protein

BQ175551

Aggrecan 1

NM_007424

Retinoic acid
receptor, beta

BB266455

Procollagen,
type IX, alpha 3

BG074456

qPCR 5p
primer
GTGATTC
CTAAGGT
GGCTTTCC
CCAATGT
TCAGGAC
GACG

qPCR 3p
primer
CTTCATTC
ACGGACCA
CAAC
CCTAGACT
GGACCATG
AAGG

GAGAGTT
TCCTTTTG
CACAACG
CTTCACTG
GGCTGCA
ATACC
CTGTGCCT
GTGAGTC
CATAC

GCTAGAGC
ACGCTTTT
GAG
GGACCACT
GTCTTACT
CCAAG
CTAAGAAC
TCTGGTGG
CCTG

GTGCAAG
AGAATTT
TGACG
GTAACAG
CAGCGTG
AAGTTGG
CCAGAAG
ATGTCTAT
GTACAAC
C
GATGAGC
AACCGTA
CCATGAC

GAAAGGA
AACTGCAT
TCAAGC
GTTTGACA
TCAGTGCC
TTGG
GGTACTGC
TACGATTT
CC

ATCGCTA
CGAGATC
AGCTCC
CAGAAGT
GCTTTGA
AGTGG
CTGAAGG
TGCTACT
76

GGTCAAAG
TGTACAAC
AGACAAA
C
CCAACACC
TACAAGCA
CAG
GAATGCAC
AGAGAGCT
ATGAG
GTTGGCAA
AGATGGTG

Probe 5p
primer
GAGAAGC
CCTTTGAG
AATGC
CAATGGA
AATAGAT
GCTGTGAA
C
CTCGGCGC
AGCATGTT
TCAG
CAATGAA
CTGGCTGA
TAGTGG
CTGTGCCT
GTGAGTCC
ATAC

Probe 3p
primer
CTTCATTC
ACGGACC
ACAAC
CCTAGACT
GGACCAT
GAAGG

GGTGGAG
AATTGCTA
CCAAGC
CATGTCA
AGTCTGTT
TTGC
CCAGTTA
ATTCTTTA
CCCAGTC
AG
GTGCAAG
CCACACT
AGAATTTT GTCACCTT
GACG
GCTAG
GTAACAG
GCAGTCA
CAGCGTG
TTCAGACC
AAGTTGG
CTAATG
CCTACTAC GCAACAA
ATCCAGGC ATGACAT
TTCC
AACTG
GATGAGC
CCTGTGTT
AACCGTAC CTGTGTGT
CATGAC
GTGTAG
GAATTGG
ACAGTAGT
GC
Did not meet
criteria to
continue
CTGGACCT
CCTGGAA

GACGGAA
CTGTCTGG
CACATC
Did not meet
criteria to
continue
CCTGGAG
ATGTTGGT

Epidermal
growth factorcontaining
fibulin-like
extracellular
matrix protein 1
Noggin

BC023060

NM_008711

Predicted
BB020678
gene/MGC99845
/Fam196b
Decorin
NM_007833
Matrilin 4

NM_013592

Scinderin

NM_009132

Procollagen,
type XI, alpha 2

AV242706

RIKEN cDNA
1700109F18
gene
Myeloid
ecotropic viral
integration siterelated gene 1
AF4/FMR2
family, member
3
Regulatory
factor X, 4
(influences HLA
class II
expression)

BB421876
BG073335

BM239026
AV255458

GATCTGC
CACCTGG
TTCCTTCT
ACTGC

AG
CAGTGTGC
TCAACAAT
GC

ACC
Did not meet
criteria to
continue

GTTC
Did not meet
criteria to
continue

CTGAGCA
AGAAGCT
GAGG
GGAACTT
CTATCGG
ACTGG
GGAAATC
CGACTTC
AATGG
GATCTCA
TCCAGGA
GTTTGG
GAGTCGA
CTGATTTT
GTGG
CAAGGCT
GGACGAA
GG
GGATCGG
GTAGGAA
GCTC
GTGCAGC
CCATGAT
AGACC

CCATCCAA
GTCTGTGC
AC
GTTCCATG
AGGTTCTC
CAG
CCAACATA
ACTGCGAT
CCCTC
GCAACTCT
GGCTACAA
GCTAG
CGAAAAG
ACTTCTGC
ACG
GGAGAAC
CTGGCATG
AAG
CTGCTGGA
GTGTGAGA
GG
GGTTTTGT
AATGGACG
GTC

CTGAGCA
AGAAGCT
GAGG
Could not
detect with
WMISH
CTCTCATC
TTCTTCCT
TCTGG
GCTATAAT
GGGCCCCT
GGATTTGG
CGTGTAGA
GAACAGT
GGTAGAG
CACTGAA
AGCTGCTG
ACATC
Did not meet
criteria to
continue
Did not meet
criteria to
continue

CCTGCTAT
TTATATCC
CAGTAC
Could not
detect with
WMISH
CCAACAT
AACTGCG
ATCCCTC
GCAACTCT
GGCTACA
AGCTAG
CCTCTGAG
GAAGTAA
TTTTGTC
GGAACCA
GCAAGAC
TTCATAAG
Did not meet
criteria to
continue
Did not meet
criteria to
continue

CAGCCAG
TCATGCA
TTAGAC
AGACCGA
TGCGTTGT
AAAG

CGACAACG
AAGATGAC
TACAG
GACATGAC
CTTGCACA
GTG

CTGATTCT
TGCTCGTC
ACAC
CAGCTAAC
CACCAGA
AGACTC

GGACCAG
AACTGTTT
TTATAAG
GACATGA
CCTTGCAC
AGTG

77

CHAPTER FOUR
PROTEOGLYCAN GENE EXPRESSION DURING Lmx1b-DIRECTED LIMB
DORSALIZATION REVEALS DISPARATE CONSERVATION BETWEEN CHICK
AND MOUSE
Jennifer M Feenstra1, Molly M. Estes1, Kerby C. Oberg 1,2

1

Division of Human Anatomy, Department of Pathology and Human Anatomy, Loma

Linda University School of Medicine; 2Division of Plastic and Reconstructive Surgery,
Department of Surgery, Loma Linda University School of Medicine

*Correspondence:
Kerby C. Oberg, MD, PhD
Department of Pathology and Human Anatomy
24785 Stewart Street,
Loma Linda, CA 92350
Tel (909) 558-7212
Fax (909) 558-0439
Email – koberg@llu.edu

78

Abstract
Many of the molecular pathways used to pattern the developing limb are
conserved across divergent species. The limb develops along three axis; proximal-distal,
anterior-posterior, and dorsal-ventral. The molecular pathway by which dorsoventral limb
patterning occurs is incompletely characterized. Lmx1b, a LIM homeodomain
transcription factor is necessary and sufficient for limb dorsalization; however,
downstream targets of Lmx1b are unknown. Identification of these downstream targets is
essential for understanding patterning of the dorsal-ventral limb axis. Previous studies
have identified several proteoglycans as potential downstream gene targets of Lmx1b. In
12.5 dpc mouse limbs, Keratocan, Lumican, and Decorin, were dorsally restricted, while
Aggrecan was not. We hypothesized the expression of these target genes would be
conserved across tetrapods. To test this hypothesis, we examined the expression of these
proteoglycans in both mouse and chick embryonic forelimbs and hindlimbs at
corresponding stages. (11.5 -14.5 dpc and Hamburger-Hamilton stages 22 - 29,
respectively) by whole mount in situ hybridization. The expression of Aggrecan was
highly conserved, localizing to condensing cartilage during the stages examined in both
mouse and chick fore/hindlimbs. In contrast the expression patterns of Keratocan,
Lumican, and Decorin was not conserved between chick and mouse. In mouse, all three
proteoglycans were initially (11.5 dpc) expressed within the dorsal mesoderm. By E14.5
Keratocan localized to the dorsal and ventral tendons, whereas Lumican and Decorin
retained dorsal expression with additional focal proximal expression within ventral
mesoderm of the hindlimb. In the chick, Keratocan and Decorin expression was initiated
in both dorsally and ventrally mesoderm progressively localizing to ventral and dorsal
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tendons. Lumican is expressed in the superficial dorsal and ventral mesoderm including
the sub-AER region. Lumican also develops diffuse dorsal and ventral mesodermal
expression in the hindlimb, beginning at HH25. The marked difference in expression
between mice and chicks during limb dorsalization was unexpected. These contrasting
expression patterns suggest that the Lmx1b-directed cascade of gene regulation during
limb dorsalization is not conserved across species. The disparity may also reflect
species-specific variations in dorsal limb evolution, structure, and function.

Introduction
Despite a variety of adult limb conformations, early vertebrate limb
morphogenesis is remarkably similar across divergent species. From fish to humans, this
observation was aptly recognized and described by 19th century embryologists such as
Karl Ernst von Baer in 1828 (Russell, 1917). Early limb development begins as a bud of
tissue emerging from the lateral plate mesoderm. Asymmetric development advances
along three coordinate axes, proximal-distal, anterior-posterior, and dorsal-ventral.
In addition, to morphology, the molecular pathways that orchestrate limb
development are largely retained. Development along the proximal-distal axis, utilizes
the apical ectodermal ridge (AER), a thickened ridge of distal ectoderm. Fibroblast
growth factors secreted from the AER stimulate growth in the underlying undifferentiated
mesoderm and progressively distalizes the limb during outgrowth. This epithelialmesenchymal interaction is conserved across vertebrate species, retaining the critical
molecules in the pathway with some minor species-specific variations (Mercader, 2007).
For example, in zebrafish Tbx5 in the presumptive fin mesoderm induces Fgf10 secretion
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which up-regulates Fgf24, Fgf16, and Fgf8 in the AER through a Wnt intermediate.
Similarly in mice, Tbx5 in the presumptive limb mesoderm up-regulates Fgf10, which in
turn induces Fgf8, Fgf4, Fgf9 and Fgf17 in the AER via intermediary Wnt genes. Thus,
the molecular pathway and downstream targets are conserved even though different
species use distinctive Fgfs to accomplish limb outgrowth.
A cluster of cells known as the zone of polarizing activity (ZPA) directs
development along the anterior-posterior axis. The ZPA secrets sonic hedgehog (Shh)
inducing proliferative limb bud expansion and distal anterior-posterior patterning. The
Shh pathway is also preserved in vertebrate appendages from fins (Dahn, Davis,
Pappano, & Shubin, 2006) to tetrapod limbs (Mercader, 2007).
The dorsal ectoderm polarizes the dorsal-ventral axis. Initially, Wnt7a is
expressed in the ectoderm overlying the presumptive limb. En-1 is up-regulated in the
ventral ectoderm as the limb bud emerges and limits Wnt7a expression to the dorsal
ectoderm (Cygan, et al., 1997). Wnt7a induces the LIM-homeodomain transcription
factor Lmx1b, in the underlying mesoderm (Vogel, et al., 1995) and Lmx1b is
responsible for limb dorsalization (Chen, et al., 1998; Riddle, et al., 1995; Vogel, et al.,
1995). The molecular mechanisms initiating dorsal-ventral axis formation in the limb are
also conserved across vertebrates (Mercader, 2007).
We wondered whether conservation of the molecular dorsal-ventral pathway in
the limb extended to downstream targets, however, the molecular cascade beyond Lmx1b
is not well characterized. Several microarray studies have been performed to identify
limb related downstream Lmx1b targets (Feenstra et al., 2012; Gu & Kania, 2010;
Krawchuk & Kania, 2008); all of these studies have discovered one or more proteoglycan
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genes up-regulated by Lmx1b during limb dorsalization. Proteoglycans are extracellular
matrix molecules that have been implicated in several developmental processes including
CNS development (Bandtlow & Zimmermann, 2000) and skeletal formation
(Waddington, Roberts, Sugars, & Schonherr, 2003).
In this report we examined the expression of proteoglycans discovered by
differential gene array analysis during limb dorsal-ventral axis formation in the mouse;
Keratocan, Lumican, Decorin, and Aggrecan. We further examined the expression in
chickens during limb development to determine whether the dorsal-ventral molecular
cascade was conserved. Mouse cells located in the dorsal limb mesoderm do not cross or
migrate to the ventral compartment after 10.5 days post coitum (dpc) (Arques, et al.,
2007; Pearse, et al., 2007; Qiu, et al., 2009), creating a distinct dorsal-ventral boundary
which may be the first step in limb dorsalization. Therefore, we examined expression of
proteoglycans beginning with compartment restriction (11.5 dpc and HH23) and ending
with differentiation of skeletal elements when Lmx1b expression decreases. Despite the
similarity of vertebrate limbs, chicks have a more derived forelimb with only three digits,
whereas the hindlimb has four digits and more closely parallels rodent limbs. Thus, to
compare target genes of the Lmx1b dorsalization pathway, we examined expression
patterns in both the forelimb and hindlimb of mice and chickens. When comparing mouse
and chick, we discovered an early disparate expression pattern for Keratocan, Lumican
and, Decorin that terminally converged within tendons.
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Materials and Methods
Brown Leghorn eggs were incubated at 39oC until Hamburger-Hamilton (HH)
(Hamburger & Hamilton, 1951) stages 22-29. CB57/bl mouse embryos were harvested at
stages 11.5, 12.5, 13.5 and 14.5 days post coitum. Embryos were harvested and fixed
overnight in MEMFA (0.1M MOPS, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde).
Digoxigenin labeled probes were used to detect Lmx1b, Keratocan, Lumican, Decorin,
and Aggrecan. Table 1 contains previously unpublished chick probe sequences, mouse
probe sequences were previously described (Feenstra, et al., 2012). Mouse and chick
Aggrecan probe sequences were derived from plasmids which were a kind gift of the
Nancy Schwartz lab (Cortes, et al., 2009). WMISH was performed as previously
described (Yamada et al., 1999) with each probe hybridized at 60oC and embryos washed
post hybridization at 65oC.
Results and Discussion
Lmx1b
As previously reported (Dreyer, et al., 2004; Vogel, et al., 1995), Lmx1b
expression is evident throughout the dorsal mesoderm of the mouse 11.5/12.5 dpc and
chick HH23/25 limb (Fig 4.1). Subsequent expression of mouse (13.5/14.5 dpc) and
chick (HH 27/29) limbs is reduced in the proximal region but remains strong distally.
Hindlimb expression is slightly delayed in both. Later stages of the mouse (13.5/14.5
dpc) display enhanced expression in the joints of the autopod. The expression and
function (Chen, et al., 1998; Vogel, et al., 1995) of Lmx1b is similar in mouse and
chicks, supporting the concept that Lmx1b is conserved across species as a mediator of
limb dorsalization.
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Figure 4.1) Lmx1b Expression Pattern Comparison
In the chick and mouse Lmx1b localizes to the dorsal limb mesoderm during limb
development. Cartoons illustrate orientation of images, dorsal limb surface and a cut
section to visualize the dorsal/ventral limb compartments. Line through the dorsal limb
view (anterior/posterior) depicts where D/V cuts were made. Lmx1b expression is
conserved between forelimb and hindlimb of the chick and mouse.
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Aggrecan
In mice, Aggrecan (Acan) expression localizes to condensing limb cartilage with
progressive development (Fig 4.2). Similarly, chick Aggrecan (ACAN) expression is
apparent by HH25 and highlights the condensing cartilage of the stylopod, zeugopod, and
distal posterior autopod. With stage progression, Aggrecan accentuates the developing
digits in a posterior to anterior pattern. By HH29, intense ACAN expression delineates the
majority of the limb skeleton. Thus, in both mice and chicks, Acan expression denotes
where cartilage condensations will form during limb skeletogenesis.
Aggrecan is an important component of the cartilage extracellular matrix, where it
forms charged aggregates within the collagen network. These charged aggregations alter
water content and binding thereby providing cartilage elasticity and compression
resistance. Loss of Acan function in the chick and mouse causes severe dwarfism (H. Li,
Schwartz, & Vertel, 1993; Watanabe et al., 1994). Similarly in humans, a homozygous
partial truncation of Acan causes severe dwarfism (Tompson et al., 2009). Our data
further supports the notion that Acan is conserved across divergent species as a molecular
component important for chondrogenesis.
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Figure 4.2) Aggrecan Expression Pattern Comparison
Aggrecan localizes to condensing cartilage of the chick (HH25/27/29) and mouse
limb(12.5/13.5/14.5 dpc). A dorsal view of the limb is shown along with a cut section to
illustrate dorsal/ventral expression differences. Aggrecan is expressed in the digits in a
posterior to anterior pattern best visualized in the chick (HH27).

Keratocan and Decorin
Keratocan, Decorin and Lumican are small leucine rich proteoglycans (SLRP)
that are important for directing collagen fibril assembly during development. These three
SLRP’s are genomically clustered together, which may suggest coordinated or possibly
redundant function. Furthermore, Keratocan (Fig 4.3) and Decorin (Fig 4.4) have a
similar expression pattern that localizes to developing tendons at HH29 and 14.5 dpc.
Keratocan expression in the mouse limb is first evident as a small region in the
proximal dorsal mesoderm at 11.5 dpc. With development, expression spreads distally to
involve the midline of the dorsal zeugopod and extends to the autopod but is absent from
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the distal digits. By 14.5 dpc, Keratocan localizes to the dorsal tendons and a few ventral
tendons of the murine limbs (Fig 4.3D, arrows).
In contrast, Keratocan within chicken limbs originates superficially in the distal
dorsal and ventral mesoderm at HH23 (Fig 4.3A). Keratocan expression continues in the
developing autopod region through HH25 (Fig 4.3B). By HH27 Keratocan expression
has expanded proximally into dorsal and ventral zeugopod mesoderm with waning
expression within the autopod and posterior clearing that excludes the region of the ZPA
(Fig 4.3C). With further development (HH29), Keratocan expression localizes to forming
dorsal and ventral tendons (Fig 4.3D).
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Figure 4.3) Keratocan Expression Pattern Comparison
In the mouse Keratocan displays dorsally restricted proximal expression, which later
localizes to tendons, arrows indicate ventral tendons. In the chick Keratocan displays
distal mesodermal expression, which localizes to dorsal and ventral tendons. Dorsal,
ventral and dorsal/ventral (DV) cut sections are shown; ventral images are flipped
horizontally to facilitate expression pattern comparison.
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Similar to Keratocan, Decorin is first expressed in the proximal dorsal aspect of
murine limbs. At 11.5 dpc, Decorin is expressed in the forelimb as a small proximal
region of dorsal mesoderm at the midline, while in the hindlimb Decorin expression
localizes to the proximal posterior aspect of the dorsal mesoderm (Fig 4.4A). Decorin
expression at 12.5 dpc broadens anteriorly within the dorsal mesoderm and also appears
proximally within the ventral mesoderm (Fig 4.4B). In the forelimb and the hindlimb at
13.5 dpc Decorin expression extends toward the autopod to lie directly below carpals (Fig
4.4C). At 14.5 dpc Decorin expression remains intense within the dorsal zeugopod with
expanded expression ventrally, condensing into presumptive dorsal and ventral
myotendinous bundles (Fig 4.4D).
Within the chicken limb at HH23, Decorin expression, like Keratocan, begins
distally within the central superficial dorsal and ventral mesoderm (Fig 4.4A). With
continued limb outgrowth (HH25-HH27), Decorin expression extends proximally to
include the zeugopod and autopod (Fig 4.4B). By HH29, Decorin expression within the
autopod clears except for limited dorsal and ventral tendon expression; however, Decorin
expression within the zeugopod mesoderm remains strong while highlighting condensing
tendons.
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Figure 4.4) Decorin Expression Pattern Comparison
Decorin displays dorsally restricted expression in the mouse beginning proximally, by
14.5dpc Decorin condenses to tendinous bundles (white arrow). In the chick Decorin
begins distally and localizes to dorsal and ventral tendons.
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Thus, in both mouse and chick limbs, Keratocan and Decorin localize to
developing tendons in due course. This localization suggests a role in tendon formation
or maturation. Supporting this concept, Keratocan and Decorin expression overlaps
Scleraxis, a marker of tendon progenitors, in the superficial mesoderm (Schweitzer et al.,
2001). Although little is known regarding the function of Keratocan in tendons, abnormal
corneal collagen fibril formation has been reported with loss of functional Keratocan in
humans and mice (Khan & Kambouris, 2004; Liu, et al., 2003). Decorin is thought to
control the rate of collagen fibril assembly (Zhang et al., 2006) and Decorin KO mice
display disrupted collagen fiber formation and skin fragility (Danielson, et al., 1997).
Together these findings suggest Keratocan and Decorin have a complementary role in
patterning the collagen composition of limb tendons.
However, there is a striking species-specific difference in the initial and evolving
expression patterns during limb development. In the mouse, expression begins
proximally and extends distally, while in the chick, expression begins distally and
extends proximally. These disparate patterns of proteoglycan expression may indicate
different mechanism of regulation to attain the same eventual localization. Alternatively,
this species-specific discrepancy could indicate a fundamental difference in how mouse
and chick tendons develop.

Lumican
In the mouse, Lumican expression is present at 11.5 dpc within the proximal
dorsal mesoderm (Fig 4.5A) and subsequently expands distally across the zeugopod by
12.5 dpc (Fig 4.5B) similar to Keratocan and Decorin. Weak ventral staining is also
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present proximally, at 12.5 dpc and increases in intensity through 14.5 dpc (Fig 4.5D).
Dorsal expression expands to include the majority of dorsal mesoderm by 13.5 dpc,
excluding the distal autopod. By 14.5 dpc, Lumican expression extends to the distal
autopod accentuating dorsal and ventral digital tendons (Fig 4.5D).
Similar to Keratocan and Decorin, Lumican expression in chick limbs at HH23
involves the central dorsal and ventral mesoderm at the distal tip (Fig 4.5A). The
expression extends along the anterior peripheral aspect of the limb. In addition, Lumican
expression is present within the zone of polarizing activity (ZPA). Thus, a band of
Lumican negative distal mesoderm separates the anterior and ZPA related areas of
expression that involve both dorsal and ventral mesoderm. The pattern persists through
HH25 with increasing expression intensity (Fig 4.5A/B). By HH25, weak Lumican
expression is also evident superficially in the zeugopod mesoderm. The anterior and
ZPA related expressions coalesce at HH27 generating a definitive sub-apical ectodermal
ridge (AER) band of expression (Fig 4.5B/C). With further development (HH29) the
superficial central limb expression in the forelimb becomes more restricted.
Concurrently, there is an overall decrease in forelimb expression including the autopod,
which highlights the sub-AER staining (Fig 4.5D). The hindlimb at this stage (HH29)
retains sub AER staining but also displays diffuse mesodermal staining of the zeugopod
and stylopod.
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Figure 4.5) Lumican Expression Pattern Comparison
Lumican displays dorsally restricted expression in the mouse and an interesting sub AER
pattern in the chick limb.

The unique sub-AER pattern of Lumican expression in chickens is similar to the
pattern of downstream Fibroblast Growth Factor target genes such as DUSP6 (C. Li,
Scott, Hatch, Tian, & Mansour, 2007) and TFAP2C (unpublished data). In the mouse
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there are no detectable levels of Lumican expression in the same sub-AER region. This
species specific difference in induction suggests that Lumican is regulated by AER
related factors such as FGF in the chick and a different molecular network in the mouse.

Conclusion
In this report we examined the expression of proteoglycans that are associated
with chondrogenesis and collagen formation during limb development in mice and
chickens. In mice, these proteoglycans are elevated in the presence of Lmx1b and
accentuated dorsally during limb development (Feenstra, et al., 2012). We confirmed
similar expression of Lmx1b expression within the dorsal mesoderm of mouse and
chicken limbs during the stages examined. We also found similar mouse and chick
expression patterns for Aggrecan, a potential downstream target of Lmx1b.
However, the expression patterns of Keratocan, Decorin and Lumican were
remarkably different in mice and chickens. In mice, the expression is first evident
proximally in the dorsal mesoderm and progresses distally with limb outgrowth. In
contrast, these proteoglycans are initially expressed distally in chick limbs and expand
proximally. Furthermore, Lumican displays an additional sub-AER expression in chicks
that is not present in mice. The initiation of expression in opposing limb regions
followed by a convergence of expression and the unique sub-AER Lumican expression
are interesting and unexpected differences between these species.
Although the expression of Lmx1b within dorsal limb mesoderm mediates limb
dorsalization across vertebrate species (Mercader, 2007), our disparate patterns of
proteoglycan expression suggest that the Lmx1b-directed cascade of gene regulation
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during limb dorsalization is not conserved across species. The disparity may also reflect
species-specific variations in dorsal limb evolution, structure, and function. Additional
studies will be needed to clarify the role of these proteoglycans in limb development.
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Abstract
Lmx1b, a LIM homeodomain transcription factor, is necessary for limb, kidney,
eye, and central nervous system development. Lmx1b knockout (KO) mice display
reduced cerebellar and tectal formation, loss of dopaminergic/serotonergic neurons,
ocular malformations, and ventral–ventral limb symmetry. The mechanism by which
Lmx1b patterns so many diverse tissues remains unclear. Recent microarray studies in
the limb have revealed multiple extracellular matrix molecules as possible downstream
Lmx1b targets. In particular, the proteoglycans Keratocan, Lumican, and Decorin
demonstrate a striking loss of expression in the Lmx1b KO mouse. Interestingly, these
proteoglycans cluster together at one genomic locus (KLD) and 5’ to this KLD locus is a
900 kilobase region devoid of coding sequences, i.e., a gene desert. Using in silico
analysis we identified 12 conserved noncoding regions (CNRs) surrounding the KLD
locus and within the gene desert. Two of these CNR’s, Peak 3 and Peak 10, contain a
known Lmx1b binding site (TAATTA or “FLAT” site). We hypothesize that Lmx1b
directly regulates KLD via CNR Peak 3 and Peak 10. We isolated the CNR regions
and linked them to a green fluorescent protein (GFP) reporter plasmid. These constructs
were electroporated into chick embryos at the primitive streak stage (HamburgerHamilton (HH) 4), during early neural tube formation (HH10), and during early limb
formation (HH14). GFP expression, and thus enhancer activity, was detected for Peak 3
in the neural tube beginning at HH10. As development progresses Peak 3 activity appears
within the developing midbrain and cerebellum. At HH19, LMX1B and KLD mRNA
expression overlap the region of Peak 3 enhancer activity. Additionally electroporation of
a 40 base pair fragment, which contains the FLAT site and several potential surrounding
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binding sites,displays localized activity similar to the complete Peak 3. This data
indicates that this 40 base pair sequence containing an Lmx1b binding site is sufficient to
produce Peak 3 activity. Our data further suggests that Lmx1b may regulate CNS
morphogenesis by altering the extracellular matrix composition such as KLD
proteoglycans. Furthermore, the activity of the minimal KLD-associated Peak 3 FLAT
site localized to Lmx1b-dependant CNS structures during development supports a direct
role for Lmx1b regulation.

Introduction
The establishment of techniques and software programs capable of genomic
alignment and analytical bioinformatics has allowed researchers to compare diverse
vertebrate genome sequences. Specifically, these methods can be used to detect cisregulatory regions found in the noncoding areas of nearby gene targets. Cis-regulatory
regions are thought to contain target sites for transcription factors thereby enhancing or
silencing nearby gene function. Since it is likely that evolutionary conservation of cisregulatory sequences occurs by fitness selection, areas of conservation across divergent
species would be the most likely target regions to convey function. Genomic comparison
studies have identified many regulatory domains, which are essential for development
(Woolfe et al., 2004). The benefits and applications of genomic comparisons are
considerable, in this report we will focus on Lmx1b, a transcription factor associated with
pattern formation of multiple organ systems with very few identified downstream targets.
Lmx1b is a LIM homeodomain transcription factor known to contribute to
patterning of the CNS, kidney, eye and limb in multiple species, however the mechanism
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by which Lmx1b patterns these tissues is not fully understood. Lmx1b plays many
important roles in CNS formation including development of the midbrain, hindbrain,
serotonergic neurons and the differentiation/migration of spinal dorsal horn neurons.
Lmx1b is expressed in the neural tube at the isthmus organizing center at 9 days post
coitum (dpc) (Guo et al., 2007) where it acts to up-regulate Fgf8 and Wnt1 to ultimately
determine the boundary between the midbrain and hindbrain (Canning, Lee, Irving,
Mason, & Jones, 2007; Crossley, Martinez, & Martin, 1996; Wurst & Bally-Cuif, 2001).
Lmx1b KO mice do not express Fgf8 or Wnt1a causing a severe reduction of the tectum
and cerebellum (Guo, et al., 2007) conversely, overexpression of Lmx1b causes
overexpression of Fgf8 and Wnt1 creating an expansion of the tectum and cerebellum
(Matsunaga, Katahira, & Nakamura, 2002). Lmx1b also interacts with the transcription
factor Pet1 to direct terminal differentiation and maintenance of serotonergic neurons
(Cheng et al., 2003; Y. Ding et al., 2003). Additionally when Lmx1b is conditionally
knocked out of Pet-1 expressing neurons all serotonergic neurons in the mouse brain are
eliminated (Zhao et al., 2007; Zhao et al., 2006). It is thought that serotonergic
dysfunction is associated with depression, post traumatic stress disorder and addiction
(Naughton, Mulrooney, & Leonard, 2000). Interestingly the double Pet-1/Lmx1b KO
mice seem to exhibit increased anxiety, possibly due to the loss of serotonin transmission
(Dai, Hu, Shi, Guo, & Ding, 2008). Lmx1b KO mice do not form synaptic contacts
between dorsal horn neurons and primary nociceptive afferent neurons, thus indicting that
Lmx1b also plays a role in assembly of pain circuitry (Y. Q. Ding et al., 2004).
The molecular mechanisms and pathways utilized by Lmx1b to regulate CNS
development are still unclear. Since Lmx1b patterns several other organ systems studies

102

identifying downstream Lmx1b target genes in other systems may aid the discovery of
CNS targets. Lmx1b has been well studied in the limb where microarray investigations
using the Lmx1b KO mouse have implicated extracellular matrix molecules as
downstream targets of Lmx1b during limb development (Feenstra et al., 2012; Gu &
Kania, 2010; Krawchuk & Kania, 2008). In particular, the small leucine rich
proteoglycan, Keratocan, was identified as a gene elevated in the presence of Lmx1b; and
in Lmx1b KO embryos, Keratocan expression was not detected by whole mount in situ
hybridization (Feenstra et al., 2012).
In an effort to identify and characterize cis-regulatory regions that Lmx1b might
utilize, we examined the genome surrounding Keratocan, which is flanked by its family
members Lumican and Decorin forming the KLD locus. Using VISTA analysis revealed
12 conserved noncoding regions (CNRs) surrounding the KLD locus. We screened
several CNRs based on their location, the degree of conservation, and whether they
contained an Lmx1b binding site. We hypothesized that Lmx1b uses one of these CNRs
to regulate Keratocan, Lumican, and/or Decorin during its multisystem development.

Materials and Methods
We identified conserved cis-regulatory regions surrounding the KLD locus using
VISTA genome browser (http://pipeline.lbl.gov/cgi-bin/GenomeVista) which uses the
human genome as a base to perform pairwise analysis with dog, mouse, opossum and
chicken (Frazer, Pachter, Poliakov, Rubin, & Dubchak, 2004). Pink peaks of
conservation indicate greater than 70% conservation over a 100 base pair segment. KLD
locus pairwise analysis was performed by entering the human chromosomal location of
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the KLD locus (Chromosome12: 89,900,717-91,055,428), this 1.15kb range represents
the region of the KLD locus up to its nearest 5’ and 3’ gene. Peaks within this region that
are at least 70% conserved in dog, mouse, opossum and chicken were labeled 1-12. Peak
sequences for each species were examined for the FLAT Lmx1b binding site (TAATTA).
Of the 12 peaks only Peak 3 and Peak10 contain a FLAT site overlapping the same
region in human, dog, mouse, and chicken. Interestingly, the opossum shows a ~200 base
pair frame shift from the other species.
Forward and reverse primer sequences were generated which isolate CNR regions
including an additional ~50bp outside the region producing an 878bp fragment for Peak 3
and 894bp for Peak 10. Primer sets in the 5’ to 3’ orientation include;
Peak 10 Forward – GCAAAGGAAATTTCTGGCTATC Peak 10 Reverse –
GTTTTGAACCACCATAGTTGTCC Peak 3 Forward CCTATTCATGACGCTGTTCATTTGC, and Peak 3 Reverse GCAATCATTTCAAGCTTGAGAACC Primers isolated the Peak 3 sequence by PCR
using chicken genomic DNA. Forward and reverse oligomers 40 bp in length were
annealed together to generate a 40 bp sequence that included the FLAT site in Peak 3, we
also generated a mutant FLAT sequence (FLATmut) that contained the same region with
the FLAT (TAATTA) site altered to form a HindIII cut site.
Primer sets in the 5’ to 3’ orientation, FLAT and HindIII sites are in bold;
FLAT Forward GCAGCTGCTAATTTGGTGATTAATTATCCATATTACACATTGA
FLAT Reverse AGCAGCTGCTAATTTGGTGATTAATTATCCATATTACACATTG
FLATmut Forward GCTGCTAATTTGGTGATAAGCTTTCCATATTACACATTGA
FLATmut Reverse AGCTGCTAATTTGGTGATAAGCTTTCCATATTACACATTG
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To generate FLAT and FLATmut fragments equimolar concentrations of forward
and reverse primers were annealed using an annealing buffer (10 mM Tris, pH 7.5–8.0,
50 mM NaCl, 1 mM EDTA) primers were boiled for 5 minutes then cooled to room
temperature over a 60 minute period. The resulting annealed primer sets were used for
further construct generation. Peak 3, FLAT and FLATmut fragments were ligated into the
pCRTM II-TOPO (Invitrogen) vector using manufacture recommended protocol.
Constructs were screened for insert and sent out to be sequenced (Eton biosciences).
Sequence confirmed pCRTM II-TOPO constructs were cut using KpnI and XhoI, inserts
were then ligated into a pTK-EGFP vector, an enhanced GFP reporter driven by the
Herpes simplex virus thymidine kinase promoter (Uchikawa, Takemoto, Kamachi, &
Kondoh, 2004). Peak 3 FLATmut construct was created with the Peak 3 pTK-EGFP
plasmid as a template along with the Forward FLATmut primer using QuikChange Multi
Site-Directed Mutagenesis Kit (Stratagene) per the manufacturer’s protocol.
Whole embryo electroporation (HH4) is performed as described in (Chapman,
Collignon, Schoenwolf, & Lumsden, 2001). 1μg of endotoxin free plasmid combined
with Fas-green dye to visualize delivery is electroporated into the embryo using 5 pulses
of 5 V for a duration of 50 ms at 100 ms intervals. Embryos are incubated on a yolk agar
plate at 370C and construct activity (GFP) is visualized with fluorescent microscopy at 24
and 48hrs.
HH10 electroporation in ovo was performed to determine construct efficacy in the
brain. Embryos/eggs were windowed, staged and stained with neutral red to facilitate
electroporation and removal of the vitelline membrane surrounding the head. 1μg of
endotoxin free plasmid and Fas green was injected into the neural tube lumen and pushed
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Figure 5.1) Depictions of pTK-EGFP and HH4/HH10 Electroporation
Since in silico analysis indicates Peak 3 and Peak 10 are likely targets of Lmx1b
regulation we generated constructs for both CNR’s using a pTK-EGFP plasmid
(Uchikawa, et al., 2004) which contains the the f1 phage origin; an upstream SV40; a
multiple cloning site (MCS); the Herpes simplex virus thymidine kinase minimal
promoter; an enhanced GFP reporter gene; and the ampicillin resistance gene (A).
Electroporation of Peak 3 and Peak 10 into the whole embryo at the primitive streak stage
allowed for detection of peak activity till HH14. Once the area of peak activity is
determined, targeted regional electroporation (TREP) can be used to demonstrate activity
in more developed organ systems such as the neural tube and developing brain (C).

cranially toward the tip of the anterior neural pore. Electrodes delivered 3 pulses of 50
ms at 10 V at 100 ms intervals. Embryos are incubated and imaged with fluorescent
microscopy at 24 and 48 hours to determine construct activity.
Screening for activity in the limb was done by TREP of the lateral plate
mesoderm between somites 14 and 21 in stage 14 chick embryos. Briefly, eggs are
windowed and embryos stained with neutral red to determine somite number and assist
removal of the vitelline membrane overlying the limb. Electroporation (EP) was
performed with 3 pulses of 50 ms at 8 V at 100 ms intervals using 2 μg/μL and fas-green.
Whole mount in situ hybridization (WMISH) was performed using antisense
digoxigen-labeled RNA probes for chick LMX1B, KERATOCAN, LUMICAN and
DECORIN. Chick LMX1B probe sequences: Forward – GGATCGCTTTCTGATGAGG,
and Reverse - CGAATGGAAGGAATGATGACATC. KERATOCAN, LUMICAN, and
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DECORIN probes were previously described (Dissertation Chapter 3, Feenstra et al 2012)
Chicks embryos were harvested at HH19/20 and fixed overnight in MEMFA (0.1M
MOPS, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde). WMISH was performed as
described (Yamada, Szendro, Prokscha, Schwartz, & Eichele, 1999) with each probe
hybridized at 60°C, and embryos were washed post hybridization at 65°C.

Results
Vista Analysis
VISTA analysis encompassed a 1.15 kilobase region which compares the human
KLD locus to the dog, mouse, opossum and chicken (Fig 5.2). Upstream of the KLD
locus lies an area devoid of other genes also known as a gene desert. Gene deserts are

Figure 5.2) VISTA Analysis of KLD Locus
VISTA output of the KLD locus comparing human to dog, mouse, opossum and chicken.
Numbers below represent 12 areas of conservation surrounding the KLD locus.
Keratocan (Kera), Lumican (Lum) and Decorin (Dec) are labeled above the human
genome (black line), analysis extends to 5’/3’ nearest neighbor genes. Pink peaks are
conserved noncoding regions (CNR), dark blue regions are exons, light blue areas are
untranslated regions. The horizontal line in each comparison represents 70%
conservation. Peak 3 and Peak 10, highlighted in purple, contain conserved Lmx1b
binding sites. Peak 10 is a small area of conservation between the 5’ untranslated region
and first exon of Keratocan.
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thought to be regions potentially rich with regulatory elements. Pink peaks denote areas
of conservation; peaks with at least 70% conservation across species are labeled 1-12.
Further analysis of Peak 3 and Peak 10 revealed each had an Lmx1b FLAT
binding site (TAATTA), which is conserved from human to chicken, suggesting that
Peak 3 and Peak 10 are likely sites for Lmx1b mediated regulation. Consequently, we
isolated Peak 3 and Peak 10 to screen for localized activity in the developing chick
embryo.

Electroporation Studies
The conserved Peak 3 and Peak 10 sequences were incorporated into reporter
constructs containing green fluorescent protein (GFP) driven by a basal herpes thymidine
kinase promoter. Without an associated enhancer, GFP expression from this plasmid is
minimal. After generating our reporter construct, we performed whole embryo
electroporation at the primitive streak stage just prior to gastrulation. Following
electroporation further development of the embryos was accomplished by incubation on a
yolk agar plate for 48 hours. GFP expression and thus, activity of the Peak sequences was
screened by fluorescent microscopy at 48 hours or approximately HH14. Results of
whole embryo electroporation reveal Peak 3 activity in the HH10 developing brain (Fig
5.3A’). No activity of Peak 10 was identified after 48 hrs (Data not shown). To localize
Peak 3 activity and correlate its activity with potential structure-related function in the
brain, we performed electroporation during early brain development at HH10. Peak 3
localized to the mesencephalon and diencephalon within the developing brain at HH19
(Fig 5.3C’).
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Figure 5.3) Peak 3 Activity in HH10 and HH19 Chick Brain
A) Light microscopy, dorsal view of HH10 brain electroporated with Peak 3 plasmid at
HH4, A’) GFP picture of same embryo shows Peak 3 activity in developing brain
vesicles. B/B’) HH4 embryo electroporated with base pTK plasmid as a negative control
C) Light microscopy, lateral view of HH19 chick head with Peak 3 neural tube targeted
electroporation performed at HH10, C’) GFP denotes Peak 3 activity in the
mesencephalon (Mes) extending slightly forward into the diencephalon (Die) but is
excluded from the telencephalon (Tel).
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Using targeted regional electroporation we transfected the lateral plate mesoderm
of the chick wing at HH14 with Peak 3 and Peak 10. Embryos were imaged with
fluorescent microscopy at 24, 48, 60 and 72 hours. No activity was detected for either
Peak 3 or Peak 10 in the developing limb.
Although Peak 3 activity was not detected in the limb, previously determined
CNS activity (Fig 5.3) indicates Peak 3 may be a regulatory region for Keratocan (Kera),
Lumican (Lum), and/or Decorin (Dec). To compare Peak 3 activity with LMX1B, KERA,
LUM and DEC expression we performed whole mount in situ hybridization at HH19.

Expression Pattern Profiles
We confirmed the previously described expression of Lmx1b (Adams, Maida,
Golden, & Riddle, 2000) in the mesencephalon and diencephalon. KERA, LUM and DEC
are also expressed in the mesencephalon and diencephalon overlapping the areas of Peak
3 activity (Fig 5.4). This convergence of proteoglycan expression and enhancer activity
supports a common regulatory mechanism. Since Peak 3 contains an Lmx1b binding site

Fig 5.4) WMISH of Lmx1b and Potential Downstream Target Genes
WMISH detected LMX1B, KERATOCAN, LUMICAN and DECORIN in the
mesencephalon (Mes), eye, telencephalon (Tel), and otic vesicle (OV). Mesencephalon
expression overlaps Peak 3 activity.
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we propose that Lmx1b binds the FLAT site to regulate the KLD proteoglycans. To test
this possible mechanism of Lmx1b regulation we created a construct containing the Peak
3 sequence with the FLAT site mutated to a HindIII cut site. Additionally we generated a
small (40 bp) region containing the FLAT site and a corresponding region with the
mutated FLAT site.

FLAT Sequence Electroporation
If Lmx1b utilizes the FLAT site to regulate Peak 3 activity then mutation of the
Lmx1b binding site should alter or ablate Peak 3 activity. Similarly, if the sequence
surrounding the FLAT site is the minimal sequence necessary for Peak 3 activity

Figure 5.5) Activity of the Lmx1b Binding Site (FLAT)
Conserved noncoding region, Peak 3, identified with Vista contains a known Lmx1b
binding site, pink box/1 (FLAT). Mutation of the FLAT site is represented by the black
box/black 2. Minimal (40bp) constructs were also generated containing the FLAT site (3)
and the HindIII mutated FLAT site (4). Embryos were electroporated at HH10 with the
four constructs, followed by imaging with florescent microscopy to detect GFP at HH19.
Peak 3 and FLAT constructs exhibit similar activity in the mesencephalon and
diencephalon. Peak 3 FLATmut and Flatmut both display expansion of activity into the
telencephalon (white arrows).
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electroporation of this minimal sequence (40bp) should show similar activity to the entire
Peak 3 sequence. If Lmx1b binding is essential to Peak 3 activity then mutation of the
FLAT site in both the entire Peak 3 and 40bp fragment should abate activity.
Interestingly, we discovered the 40bp FLAT does mimic Peak 3 activity (Fig 5.5 1/3)
while Peak 3 FLATmut and the 40bp FLATmut fragment have increased activity not
only surrounding the brain vesicles of the tectum but also extending into the
telencephalon where Lmx1b is not normally expressed (Fig 5.3 2/4). A possible reason
for this outcome is that by mutating the FLAT site to a HindIII site we may have created
a new transcription factor binding site with enhanced activity.
To evaluate whether our mutation created a new binding site we used ALIBABA,
a software program which uses TRANSFAC, a database of proven binding sites,

Figure 5.6) ALIBABA Analysis of the FLAT and MutatedFLAT Binding Sites
ALIBABA uses TRANSFAC analysis to determine possbile transcripution factor binding
sites. Note Lmx1b is not listed in the TRANSFAC database and therefore does not appear
in the results. Green region represents the FLAT site (TAATTA) while the red region
below represents the FLAT site mutated to HindIII (mFLAT). In the native sequence we
found five possible transcription factor biding sites in association with the FLAT binding
site; our mutation of the FLAT binding site disrupted all five of these native sites, but
generated 2 new binding sites.
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consensus binding sites and regulated genes to discover predicted transcription factor
binding sites. When we compare our FLAT and FLATmut sequences with ALIBABA,
our mutation disrupted 5’ flanking binding sites; however, our mutation also generated
new GATA and MCM1 binding sites (Fig 5.6). GATA transcription factors have been
implicated in CNS development (Kornhauser et al., 1994), thus, creation of this new
GATA site may have transformed the FLATmut sequence into an enhancer that is
localizing to sites of GATA expression.

Discussion
Lmx1b is expressed in the isthmus organizer, a signaling center responsible for
midbrain and hindbrain formation. Loss of Lmx1b causes a severe reduction of not only
the midbrain dopaminergic neurons but also the tectum and cerebellum (Guo, et al.,
2007). We have discovered a conserved noncoding region (CNR), Peak 3, which contains
an Lmx1b binding site and is active in the mesencephalon and diencephalon, tissues that
will form the midbrain and hindbrain region. Peak 3 lies 5’ to Keratocan, Lumican and
Decorin (KLD), we have also determined that KLD expression overlaps Lmx1b
expression and Peak 3 activity in the brain. Additionally expression of the small 40bp
fragment including the Lmx1b binding site FLAT showed the same activity as the entire
Peak 3 indicating this sequence is sufficient for Peak 3 activity. Together these results
suggest Lmb1b binds to Peak 3 thereby regulating the proteoglycans Keratocan, Lumican
and Decorin during mid/hind brain development.
No activity was detected for Peak 10 using whole embryo electroporation from
HH4-HH14 and targeted regional electroporation of the limb from HH14-25. Although
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Peak 10 may be active later in development our results suggest Peak 10 activity does not
coincide with early stages of Lmx1b patterning.
For the completion of this study we will generate a different mutation in the
FLAT site to determine activity in both the 40 bp fragment and the full Peak 3 sequence.
A loss of activity with the newly mutated FLAT site would suggest that the initial
mutation and the binding sites generated expanded enhancer activity. We are also
concurrently running a chromatin immunoprecipitation which isolates Lmx1b targeted
sequences. We will screen our Lmx1b-immunoprecipitated chromatin for Peak 3 to
determine direct Lmx1b binding. Although the FLAT site is the only currently known
Lmx1b binding site it is likely that other Lmx1b binding sites remain to be determined. It
is also likely that Lmx1b uses a currently unidentified binding site to regulate any of the
remaining 10 CNR’s surrounding the KLD locus. We will also use the ChIP-seq results
to screen for possible KLD-associated Lmx1b regulatory regions in the limb.
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Abstract
Lmx1b is a homeodomain transcription factor critical to kidney development and
glomerular filtration. In humans, Lmx1b haploinsufficiency causes a condition known as
Nail-Patella syndrome (NPS). Individuals with NPS typically have under-developed
nails, absent patellae, and impaired kidney function. In Lmx1b knockout mice, the
absence of Lmx1b function disrupts glomerular filtration and abates urine production.
The molecules targeted by Lmx1b that regulate glomerular development and function,
however, are poorly characterized. Immortalized human embryonic kidney (HEK 293)
cells provide a potential tool for high-throughput identification of Lmx1b targets and an
in vitro system for dissecting the functional role of targets. Thus, we characterized the
known Lmx1b pathway in HEK 293 cells and evaluated sites of Lmx1b binding. We
demonstrate the expression of Lmx1b and its renal targets, collagen 4 alpha 4 (Col44)
and podocin (Nphs2) in HEK 293 cells by RT-PCR. Additionally, protein expression of
Lmx1b was verified by western blot analysis. In a preliminary Chromatin
immunoprecipitation, we determined that Lmx1b binds to regulatory sequences
associated with Col44 and Nphs2. Further characterization of the Lmx1b pathway in
HEK 293 cells is underway and will likely enhance identification of relevant downstream
Lmx1b targets.
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Introduction
Throughout development, molecular pathways are routinely reused to pattern
various organs or structures. Thus key molecules used in these pathways must be capable
of patterning multiple organ systems. One such example is Lmx1b, a LIM-homeodomain
transcription factor critical for central nervous system (CNS), eye, limb, and kidney
development. Absence of Lmx1b function in Lmx1b knockout (KO) mice disrupts CNS
development, limbs exhibit a distal ventral-ventral symmetry and the kidneys are small,
lack proximal tubules and fail to produce urine (Chen, et al., 1998). Lmx1b KO mice die
shortly after birth due in part to the nephropathy The filtering units of the kidney are
convoluted vascular tufts of capillaries called glomeruli. Podocytes are a specialized type
of epithelial cell that wrap around glomerular capillaries to regulate filtration. Podocytes
secrete basement membrane components including collagens and proteoglycans. During
kidney development Lmx1b directs podocyte differentiation and maintenance. Loss of
Lmx1b causes aberrant basement membrane formation, thereby preventing normal
glomerular filtration (Rohr, et al., 2002). Despite many years of study, only two direct
downstream targets of Lmx1b have been discovered, Col44 (Morello, et al., 2001) and
Nphs2 (Rascle, et al., 2009), while other targets in the kidney remain elusive. In other
organs patterned by Lmx1b, no other direct downstream targets have been confirmed.
Although, recent microarray studies in the limb have implicated the proteoglycans
Keratocan, Lumican, and Decorin, it is unclear whether these molecules are direct or
indirect targets (Feenstra, et al., 2012). Interestingly, disruption of Lmx1b patterning
causes abnormal patterning of extracellular matrix proteins in the kidney and limb. So it
may be that discovery of downstream Lmx1b targets in the kidney will enhance and/or
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identify new limb targets.
Keratocan, Lumican and Decorin are a unique set of small leucine rich
proteoglycans tightly clustered together on the genome. Keratocan is best known for its
role in maintaining transparency in the lens of the eye by aiding collagen fibril
development and maintenance (Liu, et al., 2003). Lumican and Decorin are also
associated with collagen fibrillogenesis; in particular affecting the rate of collagen fibril
assembly, thereby giving tendons and skin their tensile strength (Rada, Cornuet, &
Hassell, 1993). Lumican and Decorin are both expressed during kidney development and
have been studied in the adult human diabetic kidney where overexpression of Lumican
and Decorin is thought to have a protective effect (Schaefer et al., 2001). Upstream of
the Keratocan, Lumican, and Decorin locus lies a 900 kb non-coding region, which
contains developmentally conserved sequences. One region (800bp), which we named
Peak3, contains an Lmx1b FLAT binding site (TAATTA) and is conserved between
human, mouse, dog, opossum and chicken. These three proteoglycans clustered on the
genome in conjunction with a conserved Lmx1b binding site and changes in proteoglycan
distribution in the Lmx1b KO mouse makes Peak3 a compelling regulatory target in the
Lmx1b cascade. We hypothesize that Lmx1b regulates Keratocan, Lumican and Decorin
(KLD) by binding to Peak3 during development.
In an effort to characterize downstream targets of Lmx1b, including Peak3, we
will use chromatin immunoprecipitation in conjunction with next generation sequencing
(ChIP-seq). ChIP-seq will help us determine Lmx1b regulation by defining genomic sites
of Lmx1b binding associated with its regulated targets. This is an important step in
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beginning to understand the mechanisms utilized by the Lmx1b to regulate morphology
and function.

Methods
Cell Culture
Human embryonic kidney cells (HEK) 293 cells were grown in 75 cm2 culture
flasks and maintained at 37oC in a humidified incubator with 5% CO2. Cells were
cultured in Dulbecco's Modified Eagle Medium (DMEM/ATTC) supplemented with 10%
fetal bovine serum (Atlanta Biologicals). A subset of HEK cells were transfected with an
pOZ-N-Lmx1b construct which contains both hemagglutinin (HA) and FLAG tags
flanking the Lmx1b (pOZ-Lmx1b-HA/FLAG, generated in collaboration with Dr. Nathan
Wall).
HEK Cell Characterization
HEK cell DNA was isolated using the DNeasy per manufacturers protocol
(Qiagen,). Primers to flank the Lmx1b binding site of Col4and Nphs2 were generated
and resulting PCR amplicons were purified and sequenced (Eton Bioscience Inc.) to
determine specificity. Primers were also generated to pull down RNA sequences for
Col44 and Nphs2, which were also purified and sequenced.
Western Blot
HEK cells were homogenized via sonication in lysis buffer containing 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, and 50 mM Tris (pH 8).
Protein (15-20 ul) was loaded into duplicate lanes of a 4-12 % Tris-glycine SDS-PAGE
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gel (Invitrogen, Carlsbad, CA). Each electrophoresis and blotting was performed using
nitrocellulose membranes at least twice. Membranes were stained with Ponceau S
solution (0.1% Ponceau in 5% acetic acid) to check for variance in sample loading. The
membranes were washed in 20 mM Tris-buffered saline solution with 0.1% Tween 20 (TTBS). Membranes were blocked in 5% powdered milk in T-TBS for 1 h at room
temperature and washed three times in T-TBS before being incubated overnight in
primary antibody solution (Lmx1b AB, donated by the Ralph Witzgall lab, diluted
1:10/Hemagglutinin AB, Sigma, diluted 1:250). After incubating in the primary antibody,
all membranes were washed three times in T-TBS and incubated in LI-COR® IRDye®
800CW Goat Anti-Mouse IgG or 680CW Goat Anti-Rabbit IgG (LI-COR®, Lincoln,
NE; T-TBS, 1:15:000) for 1 h at room temperature. LI-COR® Odyssey® Fc Imaging
System was used for detection of the protein bands.

Chromatin Immunoprecipitation (ChIP)
Cells were fixed with formaldehyde and chromatin extracted and sheared to
produce chromatin fragments of 500-250 bp (optimized as per protocol, ChIP-it Express
Enzymatic, Active Motif, Carlsbad, CA). The DNA concentration in the sheared
chromatin was determined using the Nanodrop spectrophotometer. Approximately 50 ug
of sheared chromatin was used for each immunoprecipitation. We isolated chromatin
using the HA (Sigma) antibody from HEK cells and transfected Lmx1b-HA HEK cells.
We also used the control kit (Active Motif) containing a Gapdh primer set, the RNAPolII
antibody for use as an in-run positive control and IGG as an in-run negative control. The
ChIP-Express system uses protein G magnetic beads to precipitate antibody bound to
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chromatic allowing for rapid purification of the protein-DNA complexes. The ChIPisolated DNA was then purified using the minelute QIAquick PCR purification system
(Qiagen) and DNA concentration determined using the Nanodrop spectrophotometer.
Quality control check of all ChIP DNA (input chromatin, HEK, Ha-Lmx1b HEK)
included PCR for 5’ region of Gapdh and known Lmx1b binding targets Col44 and
Nphs2.
ChIP Sequencing
We will use the University of California at Irvine (UCI) Genomics High
Throughput Facility for sequencing (http://ghtf.biochem.uci.edu/); they use an Ilumina
high throughput DNA sequencer (HiSeq 2000). We will submit 50 ng of ChIP-isolated
DNA from our HEK and Lmx1b-HA HEK cell lines. HEK cell chromatin isolated with
the HA antibody results will help identify nonspecifically bound chromatin. Results will
be compared to previously identified conserved non-coding regions upstream of the KLD
locus. In addition, results will be analyzed with the Genomic Regions Enrichment of
Annotations Tool. This online software tool
(http://great.stanford.edu/public/html/index.php) compares the location and association of
potential regulatory elements with the annotations of the surrounding or nearby coding
genes and assigns potential functional relevance to the site of binding.
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Results
HEK Cell Characterization

Previous studies have shown that Lmx1b binds the FLAT site upstream of human
Col44 (Morello, et al., 2001) and Nphs2 (Rascle, et al., 2009) using Cos7 and Hela cell
lines. We suggest that the Human Embryonic Kidney cell line (HEK) would more
accurately represent Lmx1b regulation in the developing human kidney. We began
characterization of HEK cells by demonstrating that Lmx1b, Col44, and Nphs were all
normally expressed (Fig 6.1B). We further isolated the previously described FLAT
Lmx1b binding sites associated with Col44 and Nphs2 (Fig 6.1A).

Figure 6.1) Characterization of Human Embryonic Kidney Cell Line
A.) PCR of Lmx1b and the FLAT sequence of its renal targets, Collagen 44 and
Podocin (Nphs2) using HEK 293 cell DNA. Gapdh was used as a positive control. B.)
PCR of RNA from Collagen 44 and Nphs2 using HEK cell cDNA. C.) Demonstration
of LMX1B in HEK 293 cells transduced with HA-LMX1B (293/L) by Western blot. HAtagged LMX1B is demonstrated by both HA antibodies (HA) and LMX1B antibodies
(LMX1B) (arrow ~56 kDa)
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To enable optimization of the ChIP-seq protocol without depleting our limited
supply of the ChIP proven Lmx1b polyclonal antibody, we transfected HEK cells with a
pOZ-Lmx1b-HA construct. Generation of a stable HEK293 cell line with this construct
(HEK293/L) allows us to probe for Lmx1b specific targets using commercially available
ChIP proven monoclonal antibodies to either the HA epitope or the FLAG epitope.
Using the Lmx1b antibody, Lmx1b protein was detected by western blot in both HEK293
and HEK293/L transfected cell lines (Fig 6.1C). Note, the construct generates greater
than10 times more Lmx1b that endogenously present. Thus the enhanced Lmx1b protein
levels in the HEK293/L cells (Fig 6.1 +) by western analysis overshadows the level of
Lmx1b protein visualized in control HEK cells (Fig -) although it is readily detected by
Odyssey® Fc Imaging System (data not shown). While using the HA antibody, only the
HEK293/L cells demonstrate Lmx1b protein (Fig 6.1 +). Importantly, the background
HA recognized proteins in HEK293/L are also recognized in the control HEK293 cells
(Fig6.1-).
The HEK cell line mimics in vivo conditions making it an accurate reproducible
model of Lmx1b mediated kidney development, which can be use for ChIP-seq. We were
able to enhance Lmx1b protein levels in the HEK293/L cell line. Thus, using this model
for Chip will accentuate Lmx1b targets. The unaltered HEK cell line will be used as a “in
run” negative control since we were unable to detect Lmx1b protein with the HA
antibody.
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Preliminary ChIP Results
We confirmed the effectiveness of this approach by performing a chromatin
immunoprecipitation to the known renal Lmx1b binding sites. Lmx1b bound chromatin
was isolated, fragmented and then enriched from HEK293 and HEK293/L cells using an
HA antibody. PCR confirmed the presence of Lmx1b binding sites (FLAT) to COL4 4
and Nphs2 from HEK293/L cells (Fig 6.2). FLAT sites were not found in control
HEK293 cells isolated with the HA antibody.

Figure 6.2) ChIP Results from HEK and HA-LMX1B Transduced HEK Cells
PCR following HA-immunoprecipitation (HA Ab) of human embryonic kidney (HEK)
293 cells containing the HA-LMX1B construct. Lmx1b binding sites in kidney COL44
(C) and NPHS2 (N) loci are recovered by PCR. Sheared input DNA demonstrates the
PCR fragment size of the predicted sites. The positive control uses an RNA polymerase II
antibody (RP Ab) that binds to a GAPDH associated site (G) M=Molecular weight
markers. Note absence of LMX1B COL44 and NPHS2 sites in the control HEK 293
cells using HA antibody ( ).
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Discussion
Characterization of the Lmx1b pathway in HEK293 cells will facilitate identification
of downstream targets and the molecular cascade that regulates glomerular development
and function. We have successfully isolated the FLAT sequences from Col44 and
Nphs2 from HEK cell DNA. We have also shown Lmx1b, Col44 and Nphs2 RNA
expression in the HEK cell line. Using western blot we detected Lmx1b protein in both
the HEK and HEK transfected cell lines. Together these results indicate that the HEK cell
line mimics in vivo conditions and is therefore a good model to perform ChIP-seq. PCR
following ChIP confirmed Lmx1b binding to FLAT regulatory regions of both Col44
and Nphs2.

To complete this project we will perform multiple ChIP runs to pool the chromatin
thereby allowing for sufficient chromatin to be isolated for sequencing. We expect ChIPseq results to partially overlap microarray results discussed in Chapter 3. We also expect,
since Peak3 is a very likely target of Lmx1b regulation, sequencing results from ChIP
HA isolated chromatin will include Peak3 discussed in Chapter 5. Isolation of this region
with ChIP will help determine direct Lmx1b binding.
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CHAPTER SEVEN
CONCLUSION AND FUTURE DIRECTIONS

Conclusion
Lmx1b is a homeodomain transcription factor necessary and sufficient for
dorsalizing distal limb structures. This was established over a decade ago with the
production of an Lmx1b knockout mouse (Chen et al., 1998). However, downstream
targets of Lmx1b in the limb responsible for dorsalization remain uncharacterized. We
began our search for Lmx1b target genes using the Lmx1b KO mouse model. In the
mouse, loss of Lmx1b causes scapular hypoplasia, distal ulnar hypoplasia, and loss of
soft tissue dorsalization, i.e., symmetrical ventral-ventral or flexor-flexor ligaments,
tendons and muscles (Chen & Johnson, 2002). Using microarray comparison of Lmx1b
KO and wildtype limbs we discovered skeletal, connective tissue, neuronal, and
angiogenic targets differentially expressed during Lmx1b mediated limb dorsalization.
One of the most noteworthy findings of our microarray analysis was the discovery of
several proteoglycans and proteoglycan related genes regulated by Lmx1b. The persistent
asymmetrical elevation of a cluster of proteoglycans during limb dorsalization may
provide clues to the mechanism of Lmx1b-regulated patterning.
We focused our efforts on the proteoglycans Keratocan, Lumican and Decorin for
several reasons: the preponderance of proteoglycan and proteoglycan associated genes
discovered in the microarray analysis, of all the downstream targets discovered,
Keratocan showed the greatest fold change in the microarray, all three proteoglycans

136

have a dorsally restricted expression pattern in the limb while Keratocan was
undetectable in the Lmx1b KO mouse limb, these three proteoglycans (Keratocan,
Lumican and Decorin) are closely arranged on the genome (the KLD locus) suggesting a
common or redundant mechanism of regulation and finally surrounding the KLD locus
are two regions highly conserved across species which contain an Lmx1b binding site.
The role of Lmx1b mediating limb dorsalization is conserved across vertebrate
species (Mercader, 2007). Since the developing chicken limb in ovo is accessible and
provides a model to perform temporal and spatial experimentation we continued
examination of the proteoglycans using the chick limb. We confirmed similar expression
of Lmx1b expression within the dorsal mesoderm of mouse and chicken limbs.
Unexpectedly however, the progressive patterns of Keratocan, Lumican and Decorin
expression were not conserved between chick and mouse limbs although, in both species,
these proteoglycans do eventually localize to tendons. The disparate patterns of
proteoglycan expression suggest that mechanisms regulating these genes are not fully
conserved.
Nevertheless, Keratocan demonstrated the greatest fold change in the microarray
analysis, was undetectable in the Lmx1b KO mouse and is flanked by two conserved
noncoding regions (CNRs), that contain Lmx1b binding sites. Peak 3, is upstream of the
KLD locus and exhibits enhancer activity in the mesencephalon and diencephalon, tissues
that will form the midbrain and hindbrain region. Correspondingly Lmx1b, Keratocan,
Lumican and Decorin are expressed in the isthmus organizer, a signaling center
responsible for midbrain and hindbrain formation. Loss of Lmx1b causes a severe
reduction of not only the midbrain dopaminergic neurons but also the tectum and
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cerebellum (Guo et al., 2007). In addition, activity of a small 40 base pair fragment rich
in potential binding sites, including the Lmx1b binding site (FLAT), displayed the same
activity as the entire Peak 3, suggesting that this was the minimal sequence necessary for
Peak 3 activity. The activity of KLD-associated Peak 3 localized to Lmx1b-dependant
CNS structures during development supports a direct role for Lmx1b regulation. Together
these results suggest Lmx1b binds to Peak 3 thereby regulating the proteoglycans
Keratocan, Lumican and Decorin during midbrain and hindbrain development. Our limb
focused data also suggested that Lmx1b regulates morphogenesis by altering
proteoglycan composition. Collectively, our CNS and limb related studies suggest that
modulation of proteoglycan composition is one mechanism whereby Lmx1b can regulate
morphogenesis.

Future Directions
The proteoglycans Keratocan, Lumican and Decorin lie very close along the
genome suggesting a similar or redundant function. Although individual knockout mouse
models exist for each of these genes, a compound KLD KO mouse would help determine
the function of these molecules. It is unlikely that a triple KO of Keratocan, Lumican and
Decorin KO could be accomplished by breeding individual KO mice, due to the close
proximity of these genes within the KLD locus (within 60 kb of each other). I would
propose that removal or disruption of the entire KLD locus would save resources and
time. If KLD’s regulation by Lmx1b is critical for limb development, then the KLD KO
mouse would present with aberrant dorsal limb morphology. It is likely that other Lmx1b
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patterned tissues including the eye, midbrain/hindbrain and kidney would also be
disrupted.
In addition to the proteoglycans examined in this dissertation, many other
interesting downstream Lmx1b targets were discovered in the microarray analysis
(Chapter 3). An interesting group that remains to be examined are genes associated with
scapula formation. Agc, Lum, Dec, and Lox show a reduction of scapular expression in
Lmx1b KO mice while Emx2, Matn1, and Matn4 exhibited a striking loss of scapular
expression. Since Lmx1b KO mice have hypoplastic scapulae, we propose Lmx1b works
in concert with these collective targets to augment scapular development. An interesting
way to examine Lmx1b effect on scapula development would be to knockout Lmx1b
expression from condensing cartilage. A recent study attempted this using a Sox9
promoter to induce Cre Lox removal of Lmx1b, the phenotype was very mild presenting
with distal ventralized sesmoid bones (Li, Qiu, Watson, Schweitzer, & Johnson, 2010).
Use of a similar method with an earlier marker to drive Lmx1b KO in the limb and
scapula cartilage would be a very interesting model to study the effects of Lmx1b on
skeletogenesis. Similarly a Scleraxis driven conditional Lmx1b KO would help to
determine the role of Lmx1b and the downstream targets we discovered which localize to
tendons.
Chip-seq data will be overlaid with the microarray data to confirm direct
downstream targets. Initially ChIP-seq will be done using kidney cells, thus it is likely
that not all relevant limb targets will overlap. However, with the confirmation of direct
downstream Lmx1b targets in the limb we can proceed with ChIP-seq using mouse limb
chromatin. Using our mouse colony we can harvest chromatin directly from mouse limbs
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during Lmx1b mediated dorsalization. However since we have a limited amount of ChIP
proven Lmx1b antibody available we may also use a transgenic mouse created by Dr.
Randy Johnson with a Hemagglutinin tagged Lmx1b. Access to this breeding mouse
colony would allow us to perform the ChIP on mouse limb chromatin using the Chip
proven hemagglutinin antibody.
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Abstract
Recent investigations into the mechanism of limb development have clarified the
role of several molecules, their pathways and interactions. Characterization of the
molecular pathways that orchestrate limb development has provided insight into the
etiology of many limb malformations. In this review, we describe how the insights from
developmental biology are related to clinically relevant anomalies and the current
classification schemes used to define, categorize, and communicate patterns of upper
limb malformations. We advocate an updated classification scheme for upper limb
anomalies that incorporates our current molecular perspective of limb development and
the pathogenetic basis for malformations using dysmorphology terminology. We
anticipate that this scheme will improve the utility of a classification as a basis for
diagnosis, treatment and research.

Introduction
Around 1 in 600 newborns present with some form of upper limb abnormality (1).
The molecular mechanisms that orchestrate limb development have been the focus of
intense study for several decades. Recent discoveries provide a more comprehensive
understanding of the process and greater insight into how disruption of different
molecular pathways correlates with specific presentations of upper limb anomalies.
Clinical diagnosis and treatment is enhanced by an accurate method to describe
and categorize these anomalies. Furthermore, there is a benefit for communication
between various clinicians and basic scientists if the classification scheme incorporates a
contemporary understanding of the developmental process. The most commonly used
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classification at present is based on a scheme proposed by Swanson (2) in 1964 and was
subsequently accepted by the International Federation of Societies for Surgery of the
Hand (IFSSH) in 1974 (3). This classification scheme merged the morphological
understanding of limb development with a surgical perspective on treatment. Its
simplicity promoted near universal adoption. However, its simplicity fails to group some
developmentally related anomalies, thereby allowing for either misdiagnosis or multiple
diagnoses for a related condition. Importantly, the scheme intermixes descriptive and
presumed etiologic categories. Its descriptive terminology is unable to incorporate
changes based on our increased understanding of developmental biology. Consequently,
this method of classification has generated criticism (4-9).
Despite continued progress in limb development research, a comprehensive
picture that explains a large spectrum of upper limb malformations has only recently
emerged. Manske and Oberg recently proposed several modifications to the
classification scheme based on clinical experience and developmental biology (6). The
intent of this review is to present an overview of developmental biology highlighting
current concepts of the pathogenetics of limb anomalies and to provide support for
further modifying the classification scheme to make it more relevant and useful.

Limb Development – Axis Formation and Differentiation
During early embryonic development, homeobox (HOX) transcription factors set
up a segmental body plan along the cranial-caudal axis (10). Around the fourth week of
development, the presumptive upper limb fields are established, triggering the expression
of TBX5, WNT and FGF proteins that initiate limb outgrowth (11). The upper limb bud
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emerges as a bulge of lateral plate mesoderm covered by a thin outer layer of ectoderm
(Fig A.1). Failure of limb induction, or tetramelia, is associated with WNT3 and FGF10
mutations (12;13). TBX4 and TBX5 provide clues for hindlimb\forelimb identity,
respectively. Mutations in TBX5 (Holt-Oram syndrome) (14) produce a range of upper
limb anomalies.
Following formation of the limb bud, development proceeds along three axes:
proximal-distal, anterior-posterior (radial-ulnar), and dorsal-ventral (Fig A.1).

Figure A.1) Limb Bud Coordinate Axes and Signaling Centers
A) The forelimb (boxed region) of a Carnegie stage 13 embryo depicting the three
coordinate axes – each with their own signaling center: the apical ectodermal ridge (AER
- orange) coordinating proximal-distal (Pr-Di) outgrowth and differentiation; Radial-ulnar
asymmetry is controlled by the zone of polarizing activity (ZPA - purple). Dorsalventral (Do-Ve) asymmetry is regulated by dorsal ectoderm (green); Within the progress
zone (PZ - blue) the fate of mesodermal cells are determined by these signaling centers.
The axes and signaling centers are shown in different orientations – B) Dorsal view, and
C) Lateral, end on view. (Modified from Oberg et al., 2004, used with permission)
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Development and differentiation of each axis is controlled by a population of cells that
signal patterning information to local cells and organize tissue along its axis, i.e.,
signaling centers. Mesodermal FGF10, in conjunction with ectodermal radical fringe (RFNG) at the apical dorsal-ventral boundary, induces ectodermal thickening to form the
signaling center for the proximal-distal axis, the apical ectodermal ridge (AER) (15-17).
The AER, in turn, secretes WNT3 and several FGF proteins (FGF4, 8, 9 & 17), which
maintain FGF10 expression in the underlying mesoderm. FGF10 sustains the
proliferation of a sub-AER population of cells termed the “progress zone” (PZ) (18). The
mesodermal cells within the PZ are influenced by the signaling centers to determine their
ultimate fate. This reciprocal loop of ectodermal and mesodermal FGF/WNT proteins
maintains proximal-distal outgrowth (Fig A.2 A) (19;20).
Development and differentiation along the anterior-posterior (radial-ulnar) axis is
controlled by the zone of polarizing activity (ZPA) in the posterior (ulnar) limb
mesoderm. The ZPA expands limb width and posteriorizes (ulnarizes) the developing
limb through a secreted morphogen, sonic hedgehog (SHH) (Fig. 2B & C) (21). The
AER and the ZPA are closely linked by a reciprocal feedback loop that maintains SHH
expression at the distal posterior (ulnar) border of the AER during progressive outgrowth
(22-24).
WNT7A secretion in the dorsal ectoderm regulates limb development along the
dorsal-ventral axis. WNT7A dorsalizes the underlying limb mesoderm through the
induction of the Lim homeodomain transcription factor LMX1B (Fig A.2 D) (17;25;26).
Disruption of WNT7A also disrupts ulnarization indicating an important role for WNT7A
in maintaining ZPA-related secretion of SHH (27). Thus, SHH plays a pivotal role
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during limb development, linking proximal-distal, anterior-posterior (radial-ulnar), and
dorsal-ventral axes during outgrowth (28).
The signaling centers are involved in the coordinate control of downstream targets
involved in skeletogenesis, vasculogenesis, myogenesis, and innervation, which may
involve both common, and unique, asymmetric molecular pathways. For example,
skeletogenesis requires appropriate temporal and spatial regulation of multiple factors
including SOX9 for condensation of skeletal anlagen; WNTs and GDF5 for joint
formation; and PTHLH, IHH, IGFs, BMPs, WNTs, FGFs, and RUNX2 for anlagen
growth and subsequent endochondral ossification (29). In addition, SHOX2 is upregulated in the proximal perichondrium and promotes humeral elongation, while SHOX
is induced in the forearm perichondrium and regulates radial-ulnar elongation (30;31).
Thus, appropriate induction of downstream pathways is critical to complete
differentiation along the appropriate limb axis.

Disruption of the Proximal-Distal Axis (Transverse Deficiencies)
FGFs emanating from the AER promote PZ and ZPA related limb outgrowth.
Complete removal of the AER (32) or blockade of FGF-receptor signaling (33;34)
truncates the limb along the proximal-distal axis coincident with the timing of disruption
(Fig A.2 E). These truncated limbs are akin to those described clinically for transverse
arrest and the data in animal models suggest that the level of truncation/transverse arrest
correlates with the timing of disruption (35).
Recently, Winkel and colleagues (36) demonstrated a link between WNT
signaling and ROR2, the receptor tyrosine kinase frequently mutated in brachydactyly
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type B1 (BDB1). WNTs, under the control of AER-related FGFs, contribute to
elongation of the entire limb via ROR2 receptors; thus linking abnormal function of the
AER outgrowth pathway to this form of brachydactyly and providing impetus for
inclusion as a disruption of proximal-distal development.
Intersegmental defects or phocomelias have been difficult to align with
developmental pathways and most of these fall under severe longitudinal or radial-ulnar
axis defects as described below. However, recent insights into the mechanisms and
potential roles of SHOX2 and SHOX in proximal-distal outgrowth may support some
rare intersegmental defects (30;31;37).

Disruption of the Radial-Ulnar Axis (Longitudinal Deficiencies)
Whereas complete elimination of AER-related FGF function leads to transverse
deficiencies, reduction in FGF function produces longitudinal deficiencies (Fig. 2F).
Diminished FGF function leads to a reduction in limb outgrowth, volume and width,
although proliferation and ulnarization promoted by the ZPA persists. The resulting
phenotypes are remarkably similar to the classification spectrum of radial longitudinal
deficiencies (RLD) (Fig A.2 F) (38-40). Malformation syndromes with mutations in FGF
receptor-2, such as Apert, Pfeiffer or Saethre-Chotzen, also link radial/anterior joint
abnormalities and synostoses of the arm to regulation of the FGF pathway (41).
SHH induces ulna formation in the forelimb and 4 ulnar-sided digits in the hand.
In addition, SHH is responsible for posterior (ulnar-sided) limb growth and expansion.
Progressive loss of SHH expression or targeted temporal interruption of SHH signaling
during limb development reduces limb outgrowth, volume and width (42;43). The
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phenotypes generated with SHH loss mimic those described in the spectrum of ulnar
longitudinal deficiencies (ULD) (Fig A.2 G). The clinical spectrum of ULDs probably
reflects variation in the timing, degree and duration of SHH disruption. Furthermore, the
loss of SHH can also reduce FGF expression via interruption of the SHH-FGF loop.
Thus, with reduced limb width, limb volume and FGF expression, formation of radial
structures, particularly the thumb, can also be undermined. This correlates with the
common clinical presentation of thumb deficiencies associated with ULD.
In the past, severe forms of longitudinal deficiencies that involve proximal losses
have been classified as intercalary or intersegmental defects. Careful reexamination of
many of these cases demonstrates distal defects consistent with RLD or ULD suggesting
that the proximal abnormalities represent a continuation of the longitudinal deficiency
(44;45).

Disruption of the Dorsal-Ventral Axis (Dorsalization Deficiencies)
Reduction or loss of either WNT7A in the dorsal ectoderm or LMX1B in the
dorsal mesoderm impairs dorsalization (Fig A.2 H) (46;47). In the mouse model,
haploinsufficiency does not generate a phenotype; however, in humans, single allele
disruption of LMX1B has been shown to cause Nail-Patella Syndrome, with reduced
limb dorsalization, i.e., abnormal elbow and fingernail formation (47). (dorsalization is
the embryonic term used prior to limb rotation and subsequently refers to the posterior or
extensor aspect of the upper limb and the anterior-extensor aspect of the lower limb)
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Figure A.2) Disruption of Axis Formation/Differentiation
A-D) Impact of signaling centers on normal development . A) Fibroblast growth factors
(FGFs) from the AER (orange) initiate and maintain limb outgrowth. Formation of
skeletal elements progresses from proximal to distal shown in three progressive stages
that depict arm, forearm and hand formation. B) During limb outgrowth sonic hedgehog
(SHH) emanating from the ZPA (purple) establishes an “ulnarizing” gradient (purple
arrows) and maintains posterior (ulnar) proliferation. In addition, FGFs (orange arrows)
secreted from the AER promote proliferation in the underlying progress zone
contributing to limb volume and width. C) Relative contributions of SHH (purple) and
FGFs (orange) to skeletal elements. D) Dorsal-ventral section of an embryo through the
forelimb illustrating the regulation of LMX1B (light green) by WNT7A (green).
E-H) Failure of axis formation/differentiation. E) Abrogation of AER/FGF function as
depicted in the top panel leads to transverse defects that correspond to the time of
disruption. F) Progressive reduction of FGF function leads to loss of radial structures.
G) Loss of SHH function leads to loss of ulnar-associated structures. H) Disruption of
LMX1B is associated with loss of dorsalization.
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Formation and Differentiation of the Handplate
The handplate becomes visible around the 5th week of development. HOX
transcription factors (particularly HOXD9-13 and HOXA9-13) and SHH interact to
establish digit number and identity (Fig A.3 A) (48-51). SHH also induces a posterioranterior (ulnar to radial) BMP gradient that has at least two roles in the formation and
differentiation of digits. First, BMPs induce apoptosis, or programmed cell death, within
interdigital space. This is accomplished, in part, by repressing FGF expression in the
overlying AER (52-54). Second, BMPs participate in completing digital identity via the
phalanx forming region, a region overlying the distal digital anlagen that regulates
chondrogenesis via SOX9 up-regulation and maintains the digit associated FGF in the
overlying AER for continued digital outgrowth (55). However, it is still unclear how the
various members of the BMP family (e.g., BMP2/4/5/6/7 and GDG5/6), which are
expressed in the digital and interdigital mesenchyme, establish periodic thresholds that
alternate between apoptosis and chondrogenesis.

Disruption of Interdigit Formation and Differentiation (Soft Tissue
Deficiencies)
Several natural models of persistent interdigital webbing exist, such as ducks and
bats (53;56). In both animal models, the BMP inhibitor Gremlin (GREM) is expressed
within the interdigital region, limiting apoptosis (53). Ectopic overexpression of BMP
inhibitors in the limb mesenchyme (57) and persistent FGF function in the AER or
mesoderm (54;58) inhibit interdigital apoptosis and result in syndactyly. Mutations in
Noggin (NOG), a BMP inhibitor, are clinically associated with joint synostoses,
syndactyly and polydactyly reflecting the spectrum of BMP functions.
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In Apert Syndrome, the acrosyndactyly is caused by mutations in FGF receptor 2
(FGFR2) that increase its activation affinity for FGF ligands and glycosaminoglycans
that are diffusely present in the limb mesenchyme (41;59). The continuous stimulation of
the receptor generates constitutively active signaling, i.e. always on. This constant FGF
signaling disavows interdigital BMP signals and results in complex syndactyly.
The mechanisms that convey dorsal-ventral and digit specific ligament/tendon
formation and attachment are less well-characterized. Candidate genes responsible for
flexion-contraction disorders, such as camptodactyly, may be involved in neuromuscular
interaction and/or extracellular matrix formation (e.g. PRG4). Further investigation is
needed to characterize the pathogenetic basis of these hand-related soft tissue
abnormalities.

Disruption of Digit Formation and Differentiation (Skeletal
Deficiencies)
As described above, abrogation of SHH results in the loss of ulnar digits, a
disruption of the radial-ulnar axis. However, abnormalities in the SHH signaling cascade
can also yield polydactylies. GLI3, a transcription factor involved in SHH signaling,
accentuates the functional gradient of SHH across the radial-ulnar axis (Fig A.3 B). In
the radial aspect of the limb bud, GLI3 undergoes post-transcriptional modification into a
shortened repressor form that counters SHH action on target cells. In the region of the
ZPA, SHH blocks GLI3 modification to yield the full length activator form (60-62).
Mutation of this bi-functional transcription factor can cause ulnar polydactyly (also called
postaxial polydactyly types A & B) (63;64) and radial polydactyly (preaxial polydactyly
type IV) with syndactyly (65). In mice, the complete absence of GLI3 causes a loss in
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digit identity (Fig A.3 B) (60), which is morphologically similar to the human condition
of a five-fingered hand or a non-opposable triphalangeal thumb (66). Additionally,
mutations in the limb-specific SHH regulatory region cause abnormal anterior (or radial)
expression of SHH and yield triphalangeal thumbs (67;68).
Disruption of HOXD13 (69) or deletion of the entire HOXD9-13 region (70)
results in variant forms of synpolydactyly, a disorder characterized by disorganized
digit/interdigit formation and identity (Fig A.3 C). Loss of HOXA13 function is
associated with Hand-foot-genital Syndrome which exhibits hypoplastic middle
phalanges and digit deviation (71;72).
Digit formation, segmentation and cartilage maturation involve multiple factors
and pathways. Thus, mutation or disruption of many of these may result in shortened
digits or brachydactyly. Mutations in Hoxd13 can cause brachydactyly type D and E1.
Disruption of factors involved in cartilage maturation also cause brachydactyly, including
IHH, (type A1), BMPR1B (type A1 and A2), Gdf5 (type A2 and C), ROR2 (Type B1),
NOG (Type B2) and PTHLH (type E2).
During digit formation and differentiation, BMPs regulate the transition between
digital SOX9 activation and FGF maintenance in the overlying AER. Complete absence
of SOX9 results in regression of the limbs since cartilage formation is not induced (73).
Haploinsufficiency of SOX9 results in camptomelic dysplasia with reduced cartilage
formation, bowing of long bones and brachydactyly.
Ogino generated a model of central deficiency (cleft or split hand) (74) using the
alkylating chemotherapeutic agent Busulfan. For a brief window during handplate
development, the teratogen caused increased apoptosis in the distal progress zone and

153

AER leading to central clefting, central syndactyly, and central digit duplication (Fig A.3
D). The increase in handplate apoptosis also resulted in disruption of AER-related FGF
expression, reduced and irregular BMP4 expression from the AER and underlying
mesoderm, and reduced ZPA-related SHH expression (75). Thus, these data link the
clefting, syndactyly, and polydactyly of central deficiency to a common, albeit
molecularly complicated, mechanism during handplate formation.
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Figure A.3) Disruption of Handplate Formation/Differentiation
A) From left to right: during early handplate formation SHH and HOX transcription
factors create a posterior to anterior gradient (ulnar-radial; purple to peach) that
establishes interdigital (ID) signaling centers, digital anlagen and a BMP gradient (brown
to yellow). The BMP gradient participates in conveying digital and ID fates via the
phalanx forming region (PFR – fuchsia region capping digits) and repression of the AER,
respectively (arrows).
Apoptosis in the ID region ensues with regression of the
associated AER (stippled region). Overlying the digit, the AER persists and outgrowth
continues as the PFR regulates digit construction. B) Expression pattern of SHH-related
GLI3 expression: GLI3 repressor (GLI3r) predominates in the radial aspect of the
developing limb, while GLI3 activator (GLI3a) surrounds the ZPA. In the complete
absence of GLI3 (rather than targeted mutations as in the human), the digit number is
expanded and the unique ulnar-radial digit identity is lost generating identical “default”
digits. C) The nested expression pattern of HOXD9-13 is represented by HOXD9,
HOXD11 and HOXD13. In the absence of HOXD9-13, the hand exhibits synpolydactyly
with excessive carpals, irregular digital elements and loss of alternating ID regions. D)
From left to right: The central distal region of the handplate appears to be particularly
sensitive to disruption (cross hatched). Teratogenic exposure can induce cell death in the
AER (1), the ID region (2) or both (3) resulting in partial duplication (1), syndactyly (2)
or cleft hand (3),respectively. In all images the thumb is up. Note - typically the central
or third digit is the primary target for disruption with clefting and duplication. Digit two
(D, center and right) is used to permit a collective illustration.
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Relationship to Classification
The insights gained from our increasing knowledge of developmental biology do
not align with the IFSSH/Swanson classification scheme. During development, the
molecular pathways that organize and define the unique asymmetries of the upper limb
are established, i.e. the proximal-distal, anterior-posterior (or radial-ulnar) and dorsalventral axes. Disruption of these developmental pathways causes consistent
abnormalities affecting the formation of the entire limb along these axes. Under the
IFSSH/Swanson classification, the conditions classified in IFSSH Group I - “Failure of
Formation” tend to emphasize axis- related abnormalities that affect the proximal limb
(i.e., arm and forearm) which may extend to the hand. Consequently, it would be
reasonable to group these conditions together into a category reflecting the etiology and
global impact, i.e. Failure of Axis Formation/Differentiation – Entire Upper Limb, and to
include sub-categories which indicate which axis is primarily involved.
The conditions listed under IFSSH Group 2 “Failure of Differentiation” tend to
emphasize abnormalities of handplate formation and differentiation, rather than
abnormalities of differentiation alone. Polydactyly, currently within IFSSH Group III –
“Duplication” also involves failures of formation and differentiation affecting the
anterior-posterior (radial-ulnar) axis. Exclusion of polydactyly from Groups I or II
appears illogical. These handplate-limited malformations can be sub-categorized
according to whether they disrupt axis formation and/or differentiation, e.g.,
polydactylies which by common definition are axial (radial-ulnar) defects, or whether
they disrupt generalized handplate formation and/or differentiation (unspecified axis) e.g.
syndactyly. Moreover, none of these IFSSH Groups adequately address the variety of
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malformations evident in cleft hands, which prompted the Japanese Society of Hand
Surgery (JSSH) to propose the addition of another group within the IFSSH/Swanson
classification - “Abnormal Induction of Digital Rays” (76)
IFSSH Group IV - “Overgrowth” is a descriptive term that does not convey a
mechanism of etiology. Similarly, IFSSH Group V - “Undergrowth” is nonspecific,
uninformative regarding etiology, and the inclusion of disorders within the category
appears arbitrary. Undergrowths such as brachymelia with brachydactyly or
symbrachydactyly involve molecular pathways consistent with transverse deficiencies,
while undergrowths such as longitudinal deficiencies are excluded from this category.
Although IFSSH Group VII - “Generalized Skeletal Disorder” noted syndromic
entities, as the number of defined genetic syndromes with upper limb malformations and
diverse skeletal involvement has accumulated, it has become less meaningful to separate
these into a separate category rather than the presenting limb morphologies.
Our increased understanding of limb morphogenesis and dysmorphogenesis has
accentuated problems of the IFSSH/Swanson classification and prompted surgeons,
pathologists and geneticists working in the field of congenital limb anomalies to question
the adequacy of this classification (4-6;8;9).
The terminology of dysmorphology offers a framework for conveying the
etiology of congenital limb anomalies (77). A Malformation is an abnormal formation of
a body part or complex tissue. Deformation differs from a malformation as the insult
occurs after normal formation. A Dysplasia is an abnormality in the size, shape, and
organization of cells within a tissue. Dysmorphologists describe a fourth term,
Disruption. As this process involves alteration of tissue which is already formed, for the
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purposes of classification, it is reasonable to include those conditions which are
considered to be Disruptions alongside those considered to be Deformations.
Although the pathogenesis of some specific anomalies remains obscure, the
concept of separating malformations, deformations and dysplasias provides a sound
structure for categorizing congenital upper limb anomalies. Therefore, to align the
classification scheme with our current understanding of limb development at a molecular
level using dysmorphology terminology, we recommend three broad categories –
Malformations, Deformations and Dysplasias. Malformations are further subdivided
according to the axis of development which is predominantly affected and whether the
defect involves the entire limb or restricted primarily to the hand. Incorporation of the
above principles results in a classification scheme as follows:

I. Malformations
I A.

Failure of Axis Formation/Differentiation – Entire Upper Limb
To more accurately reflect the pathogenesis of many of the malformations currently

listed under IFSSH Group 1 - “Failure of Formation” we recommend a subcategory
entitled “Failure of Axis Formation/Differentiation – Entire Upper Limb” with three
divisions reflecting the three axes that can be disrupted (see table A.I). We include
brachydactylies that impact the entire limb (Symbrachydactyly, and brachydactyly type
B1) under defects of the proximal-distal axis together with transverse deficiencies and
intersegmental deficiencies. Defects of the radial-ulnar axis include not only radial and
ulnar longitudinal deficiencies, but also radial and ulnar duplications such as ulnar
dimelia, and radial-ulnar synostosis (previously listed under IFSSH Group III -
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“Duplications” and IFSSH Group II - “Failure of Differentiation”, respectively). We
further add defects of the dorsal-ventral axis such as Nail-Patella Syndrome. This would
bring together malformations that alter the unique upper limb asymmetries and tend to
have a more comprehensive effect on limb development (which may also include the
hand).

I B.

Failure of Axis Formation/Differentiation – Handplate
Axial defects limited to the handplate are separated into the second subcategory.

Previously, the polydactylies were considered duplication defects; however, these
typically can be attributed to disruption of an axial signaling pathway. For example,
disruption of GLI3 function, a transcription factor involved in the definition of the radialulnar axis, can cause preaxial polydactyly (type IV – or polysyndactyly) (78) and ulnar
(postaxial) polydactyly (type A1) (65).
We also include triphalangeal thumbs in this group. Recent genetic studies of radial
polydactyly (preaxial polydactyly type II) found point mutations in or duplications of the
limb specific SHH regulatory region (79-81). In animal models similar point mutations
induce ectopic radial SHH expression and preaxial polydactyly (82-84).
Disruption of the dorsal-ventral axis can also be limited to the handplate such as in
dorsal dimelia; therefore such malformations are also included within this subsection.

I C.

Failure of Hand Plate Formation and Differentiation – Unspecified Axis
The malformations listed under IFSSH Group II - “Failure of Differentiation”

involve primarily, but not exclusively, handplate development. We have combined
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defects limited the handplate that are not related to axis disruption under “I C”. For
example, abnormalities that involve the distinctly hand-associated pathways that regulate
interdigit formation and digit/phalanx designation are placed in this category. We also
include malformations that probably involve multiple pathways such as synpolydactyly
and cleft hand. Ogino and coworkers demonstrated that a single insult to the developing
handplate can lead to syndactyly, central polydactyly or cleft hand (74;75;85). This
demonstrates a link between these conditions, but not necessarily that the presence of one
is obligatorily associated with that of the others.

II. Deformations
According to the terminology of dysmorphology, we have established a second
category for deformation or disruption of any portion of a limb that has already been
formed. Within this category “Constriction Ring Sequence” is listed which may be
syndromic or related to amniotic banding. Arthrogryposis or congenital contracture can
be isolated or involve multiple joints and have several etiologies including neurological,
muscular or connective tissue (86;87). Arthrogryposis is also included in this category
because the formation of contractures, typically evident during mid-gestation, occurs
after joint and skeletal formation (88). Trigger digits are also included as deformations
since they typically present in childhood rather than at birth. Deformations or
disruptions from viral infection, vascular insults or mechanical damage do not typically
follow a consistent pattern and, for the sake of classification, would be listed under
subcategory D – “Not Otherwise Specified”.
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III. Dysplasias
Dysplasias include conditions which have previously been listed according to
their appearance and are a unique group associated with cellular atypia or tumor
formation. Limb hypertrophy which occurs in conjunction with tumor formation or
macrodactyly which appears to be cellular dysplasia in response to some as of yet
unknown factor are examples. These were previously classified within IFSSH Group II “Failure of Differentiation” (tumorous conditions) or purely as a descriptive term within
IFSSH Group IV - “Overgrowth”. There may be dissent as to whether these conditions
are in fact malformations or deformations and further insights from developmental
biology may prompt transfer of a specific entity to either our Group I or Group II.
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Table A.1) Comparison of the current classification scheme and proposed modifications.
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Conclusion
Congenital anomalies in the hand and upper limb demand a reproducible and
consistent terminology, a universal language which allows discussion of complex clinical
entities, indications for treatment and comparisons of results. As our understanding of
the molecular basis of morphogenesis and dysmorphogenesis continues to progress, the
way that we categorize these disorders must also continue to be refined. This
classification may also need revisions in the future; however, we believe that the use of
dysmorphology terminology will provide an appropriate framework to easily
accommodate further refinements.
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